<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:45:13Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9009710" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9009710</identifier>
        <datestamp>2022-04-15</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9009710</article-id>
              <article-id pub-id-type="pmcid">PMC9009710</article-id>
              <article-id pub-id-type="pmc-uid">9009710</article-id>
              <article-id pub-id-type="pmid">35421086</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0262955</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-21-29252</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Physiological Processes</subject>
                      <subj-group>
                        <subject>Sleep</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Neuropsychiatric Disorders</subject>
                      <subj-group>
                        <subject>Anxiety Disorders</subject>
                        <subj-group>
                          <subject>Post-Traumatic Stress Disorder</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Neuroses</subject>
                      <subj-group>
                        <subject>Anxiety Disorders</subject>
                        <subj-group>
                          <subject>Post-Traumatic Stress Disorder</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Physics</subject>
                    <subj-group>
                      <subject>Electromagnetic Radiation</subject>
                      <subj-group>
                        <subject>Light</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Clinical Medicine</subject>
                    <subj-group>
                      <subject>Signs and Symptoms</subject>
                      <subj-group>
                        <subject>Pain</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Critical Care and Emergency Medicine</subject>
                    <subj-group>
                      <subject>Trauma Medicine</subject>
                      <subj-group>
                        <subject>Traumatic Injury</subject>
                        <subj-group>
                          <subject>Neurotrauma</subject>
                          <subj-group>
                            <subject>Traumatic Brain Injury</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Biomarkers</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Sleep Disorders</subject>
                      <subj-group>
                        <subject>Dyssomnias</subject>
                        <subj-group>
                          <subject>Insomnia</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Neurology</subject>
                    <subj-group>
                      <subject>Sleep Disorders</subject>
                      <subj-group>
                        <subject>Dyssomnias</subject>
                        <subj-group>
                          <subject>Insomnia</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Physiology</subject>
                    <subj-group>
                      <subject>Immune Physiology</subject>
                      <subj-group>
                        <subject>Cytokines</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune System</subject>
                      <subj-group>
                        <subject>Innate Immune System</subject>
                        <subj-group>
                          <subject>Cytokines</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Immunology</subject>
                    <subj-group>
                      <subject>Immune System</subject>
                      <subj-group>
                        <subject>Innate Immune System</subject>
                        <subj-group>
                          <subject>Cytokines</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Developmental Biology</subject>
                    <subj-group>
                      <subject>Molecular Development</subject>
                      <subj-group>
                        <subject>Cytokines</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Feasibility and preliminary efficacy for morning bright light therapy to improve sleep and plasma biomarkers in US Veterans with TBI. A prospective, open-label, single-arm trial</article-title>
                <alt-title alt-title-type="running-head">Bright light therapy to improve sleep and biomarkers in Veterans with TBI. An open-label, single-arm trial</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6992-6851</contrib-id>
                  <name>
                    <surname>Elliott</surname>
                    <given-names>Jonathan E.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McBride</surname>
                    <given-names>Alisha A.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Balba</surname>
                    <given-names>Nadir M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Thomas</surname>
                    <given-names>Stanley V.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pattinson</surname>
                    <given-names>Cassandra L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Morasco</surname>
                    <given-names>Benjamin J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <xref rid="aff007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="aff008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="aff010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3586-2105</contrib-id>
                  <name>
                    <surname>Wilkerson</surname>
                    <given-names>Andrea</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
                  <xref rid="aff011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Gill</surname>
                    <given-names>Jessica M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <xref rid="aff006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Lim</surname>
                    <given-names>Miranda M.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/resources/">Resources</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <xref rid="aff009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="aff011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                  <xref rid="aff012" ref-type="aff">
                    <sup>12</sup>
                  </xref>
                  <xref rid="aff013" ref-type="aff">
                    <sup>13</sup>
                  </xref>
                  <xref rid="aff014" ref-type="aff">
                    <sup>14</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>VA Portland Health Care System, Research Service, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Neurology, Oregon Health &amp; Science University, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Department of Behavioral Neuroscience, Oregon Health &amp; Science University, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>Department of Medicine, Creighton University, Omaha, Nebraska, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>University of Queensland, Institute for Social Science Research, Queensland, Australia</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>National Institutes of Health, National Institute of Nursing Research, Bethesda, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff007">
                <label>7</label>
                <addr-line>VA Portland Health Care System, Mental Health, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff008">
                <label>8</label>
                <addr-line>VA Portland Health Care System, Center to Improve Veteran Involvement in Care, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff009">
                <label>9</label>
                <addr-line>VA Portland Health Care System, Mental Illness Research Education and Clinical Center, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff010">
                <label>10</label>
                <addr-line>Department of Psychiatry, Oregon Health &amp; Science University, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff011">
                <label>11</label>
                <addr-line>Pacific Northwest National Laboratory, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health &amp; Science University, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff012">
                <label>12</label>
                <addr-line>Oregon Health &amp; Science University, Oregon Institute of Occupational Health Sciences; Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff013">
                <label>13</label>
                <addr-line>VA Portland Health Care System, Neurology, Portland, Oregon, United States of America</addr-line>
              </aff>
              <aff id="aff014">
                <label>14</label>
                <addr-line>VA Portland Health Care System, National Center for Rehabilitative Auditory Research, Portland, Oregon, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Abdelbasset</surname>
                    <given-names>Walid Kamal</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Prince Sattam Bin Abdulaziz University, College of Applied Medical Sciences, SAUDI ARABIA</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>lmir@ohsu.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>14</day>
                <month>4</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>17</volume>
              <issue>4</issue>
              <elocation-id>e0262955</elocation-id>
              <history>
                <date date-type="received">
                  <day>13</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>20</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="cc0license">https://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref>
                  <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0262955.pdf"/>
              <abstract>
                <p>Mild traumatic brain injury (TBI) is associated with persistent sleep-wake dysfunction, including insomnia and circadian rhythm disruption, which can exacerbate functional outcomes including mood, pain, and quality of life. Present therapies to treat sleep-wake disturbances in those with TBI (e.g., cognitive behavioral therapy for insomnia) are limited by marginal efficacy, poor patient acceptability, and/or high patient/provider burden. Thus, this study aimed to assess the feasibility and preliminary efficacy of morning bright light therapy, to improve sleep in Veterans with TBI (NCT03578003). Thirty-three Veterans with history of TBI were prospectively enrolled in a single-arm, open-label intervention using a lightbox (~10,000 lux at the eye) for 60-minutes every morning for 4-weeks. Pre- and post-intervention outcomes included questionnaires related to sleep, mood, TBI, post-traumatic stress disorder (PTSD), and pain; wrist actigraphy as a proxy for objective sleep; and blood-based biomarkers related to TBI/sleep. The protocol was rated favorably by ~75% of participants, with adherence to the lightbox and actigraphy being ~87% and 97%, respectively. Post-intervention improvements were observed in self-reported symptoms related to insomnia, mood, and pain; actigraphy-derived measures of sleep; and blood-based biomarkers related to peripheral inflammatory balance. The severity of comorbid PTSD was a significant positive predictor of response to treatment. Morning bright light therapy is a feasible and acceptable intervention that shows preliminary efficacy to treat disrupted sleep in Veterans with TBI. A full-scale randomized, placebo-controlled study with longitudinal follow-up is warranted to assess the efficacy of morning bright light therapy to improve sleep, biomarkers, and other TBI related symptoms.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000738</institution-id>
                      <institution>U.S. Department of Veterans Affairs</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1K2 BX002712</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Lim</surname>
                      <given-names>Miranda M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000738</institution-id>
                      <institution>U.S. Department of Veterans Affairs</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>1K2 RX002947</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6992-6851</contrib-id>
                    <name>
                      <surname>Elliott</surname>
                      <given-names>Jonathan E.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution>National Institutes of Health, National Center for Complementary and Alternative Medicine</institution>
                  </funding-source>
                  <award-id>AT002688</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6992-6851</contrib-id>
                    <name>
                      <surname>Elliott</surname>
                      <given-names>Jonathan E.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution>National Institutes of Health, National Center for Complementary and Alternative Medicine</institution>
                  </funding-source>
                  <award-id>AT002688</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Balba</surname>
                      <given-names>Nadir M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award005">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100013130</institution-id>
                      <institution>Center for Neuroscience and Regenerative Medicine</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>309698-7.01-65310</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Lim</surname>
                      <given-names>Miranda M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award006">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100013130</institution-id>
                      <institution>Center for Neuroscience and Regenerative Medicine</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>309698-7.01-65310</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Gill</surname>
                      <given-names>Jessica M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award007">
                  <funding-source>
                    <institution>Oregon Institute for Occupational Health Sciences Pilot Project Award</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <name>
                      <surname>Lim</surname>
                      <given-names>Miranda M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award008">
                  <funding-source>
                    <institution>NIH EXITO Institutional Core</institution>
                  </funding-source>
                  <award-id>UL1GM118964</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Lim</surname>
                      <given-names>Miranda M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award009">
                  <funding-source>
                    <institution>National Institutes of Health</institution>
                  </funding-source>
                  <award-id>TL1TR002371</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Balba</surname>
                      <given-names>Nadir M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This material is the result of work supported with resources and the use of facilities at the VA Portland Health Care System, VA Career Development Award #1K2 BX002712, Oregon Institute for Occupational Health Sciences Pilot Project Award, NIH EXITO Institutional Core, #UL1GM118964, and the Portland VA Research Foundation to M.M.L.; VA Career Development Award #1K2 RX002947 to J.E.E; NIH T32 AT002688 to J.E.E and N.M.B.; NIH TL1 TR002371 to N.M.B.; Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine #309698-7.01-65310 to M.M.L. and J.M.G.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Interpretations and conclusions are those of the authors and do not represent the views of the U.S. Department of Veterans Affairs, the National Institute of Health, or the United States Government.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="8"/>
                <table-count count="3"/>
                <page-count count="24"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Relevant data are contained within the manuscript as well as stored on the REDCap database. A de-identified, anonymized dataset will be made available by request to any interested investigators together with a data dictionary to enable interpretation.” The DOI to our minimal data set is: <ext-link xlink:href="https://doi.org/10.5061/dryad.rjdfn2zcr" ext-link-type="uri">https://doi.org/10.5061/dryad.rjdfn2zcr</ext-link>.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Relevant data are contained within the manuscript as well as stored on the REDCap database. A de-identified, anonymized dataset will be made available by request to any interested investigators together with a data dictionary to enable interpretation.” The DOI to our minimal data set is: <ext-link xlink:href="https://doi.org/10.5061/dryad.rjdfn2zcr" ext-link-type="uri">https://doi.org/10.5061/dryad.rjdfn2zcr</ext-link>.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Traumatic brain injury (TBI) is a public health concern associated with staggering functional and economic burden, especially in the Veteran population, contributing to a plethora of short- and long-term sequelae [<xref rid="pone.0262955.ref001" ref-type="bibr">1</xref>]. Principal among these complications are sleep-wake disturbances [<xref rid="pone.0262955.ref002" ref-type="bibr">2</xref>–<xref rid="pone.0262955.ref004" ref-type="bibr">4</xref>]. TBI-related sleep-wake disturbances have been documented several years post-injury [<xref rid="pone.0262955.ref005" ref-type="bibr">5</xref>], with recent work suggesting persistence of symptoms &gt;20 years post-injury [<xref rid="pone.0262955.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0262955.ref008" ref-type="bibr">8</xref>]. Multiple mechanisms may explain the pathophysiology underlying persistent sleep disturbances after mild TBI, including but not limited to, damage to cortical pathways related to glutamate/GABA balance and/or orexin/hypocretin neurons, with subsequent effects on circadian-regulated systems such as melatonin, and others [<xref rid="pone.0262955.ref009" ref-type="bibr">9</xref>–<xref rid="pone.0262955.ref013" ref-type="bibr">13</xref>].</p>
              <p>Sleep is critical for optimal brain function and general health, including cognition, mood, and resilience to chronic pain [<xref rid="pone.0262955.ref014" ref-type="bibr">14</xref>–<xref rid="pone.0262955.ref018" ref-type="bibr">18</xref>]; especially following TBI [<xref rid="pone.0262955.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0262955.ref020" ref-type="bibr">20</xref>]. Thus, sleep problems in TBI almost certainly exacerbate dependent functional outcomes such as cognition, mood, and chronic pain [<xref rid="pone.0262955.ref021" ref-type="bibr">21</xref>–<xref rid="pone.0262955.ref023" ref-type="bibr">23</xref>]. Current interventions to treat sleep-wake disturbances in those with TBI are limited by marginal efficacy, poor patient acceptability, and/or high patient/provider burden (e.g., medications, acupuncture, cognitive behavioral therapy for insomnia) [<xref rid="pone.0262955.ref024" ref-type="bibr">24</xref>–<xref rid="pone.0262955.ref026" ref-type="bibr">26</xref>]. In particular, Veterans are a unique population with not only high rates of TBI, but also high rates of mental health comorbidities and are also at higher risk for cognitive impairment, both of which may limit the number of treatment options available. Thus, alternative treatment approaches are needed in this population, particularly treatment options that are feasible, have high acceptability, are low burden, and have minimal side effects.</p>
              <p>Light therapy has garnered more attention recently due to the possibility of circadian rhythm disruption in TBI as well as effects on sleep, mood and daytime alertness [<xref rid="pone.0262955.ref027" ref-type="bibr">27</xref>–<xref rid="pone.0262955.ref037" ref-type="bibr">37</xref>]. Recent work from Killgore <italic toggle="yes">et al</italic>. in 2020 compared the effects of blue spectrum light with a placebo control amber light on sleep in individuals with TBI, and found improvement in subjective daytime sleepiness, although objective measures of sleep via actigraphy were unchanged [<xref rid="pone.0262955.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0262955.ref039" ref-type="bibr">39</xref>]. Two other recent studies examined light therapy on daytime fatigue in individuals with TBI (including severe) [<xref rid="pone.0262955.ref040" ref-type="bibr">40</xref>,<xref rid="pone.0262955.ref041" ref-type="bibr">41</xref>]. Additionally, light therapy was also recently shown to improve post-traumatic stress disorder (PTSD) symptom severity in Veterans with PTSD, albeit without a change in self-reported or actigraphic metrics of sleep quality [<xref rid="pone.0262955.ref042" ref-type="bibr">42</xref>]. However, to our knowledge, no studies on light therapy have examined effects on sleep in Veterans with TBI. Light therapy is delivered at home and requires little cognitive burden and therefore may be more widely applicable and acceptable to those with cognitive impairment, as is commonly reported in Veterans with TBI [<xref rid="pone.0262955.ref043" ref-type="bibr">43</xref>]. Finally, light therapy has few adverse side-effects, other than select pre-existing conditions (e.g., bipolar disorder and macular degeneration), and thus may be preferable to pharmacologic approaches [<xref rid="pone.0262955.ref044" ref-type="bibr">44</xref>].</p>
              <p>We sought to examine the feasibility and preliminary efficacy of light therapy, using a lightbox to deliver white light (10,000 lux at the eye) in the morning, over 4-weeks. The chosen brand is commercially available, has been in use for decades, and was validated with regard to illuminance measures for this study. The chosen dose, timing, and duration is established for seasonal affective disorder and has been shown to affect circadian entrainment [<xref rid="pone.0262955.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0262955.ref044" ref-type="bibr">44</xref>–<xref rid="pone.0262955.ref046" ref-type="bibr">46</xref>], but direct effects on sleep in the Veteran TBI population have not yet been examined. Thus, in addition to feasibility/limited efficacy outcomes, the current study sought to provide preliminary evidence for light therapy to improve sleep in Veterans with a history of TBI. We hypothesized that morning bright light therapy would be feasible, acceptable, and show improvement in both subjective and objective sleep in Veterans in the chronic phase of recovery from mild TBI.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and methods</title>
              <p>The VA Portland Health Care System approved this study, and each subject gave written and verbal informed consent prior to participation (IRB#4085). In this prospective study, Veterans (<italic toggle="yes">n</italic> = 54) were identified from the VA Portland Health Care System Sleep Clinic between 08/2017 and 08/2018. Subjects were excluded if they were not Veterans, currently diagnosed with bipolar disorder, dementia, depression, or macular degeneration, and were either currently using a lightbox or a shift-worker (<italic toggle="yes">n</italic> = 8). No subjects reported using melatonin, and the use of other sleep medications were not excluded for. Eligible subjects (<italic toggle="yes">n</italic> = 46) were consented and further evaluated for TBI by a licensed physician using the Head Trauma Events Characteristics (HTEC; recommended by the Department of Defense and the Department of Veteran Affairs [<xref rid="pone.0262955.ref047" ref-type="bibr">47</xref>]), consisting of a ~20-minute diagnostic interview. In total, <italic toggle="yes">n</italic> = 13 were excluded for not meeting HTEC-defined criteria for sustaining mild TBI. The remaining <italic toggle="yes">n</italic> = 33 subjects, unless otherwise noted, were included in subsequent analyses (<xref rid="pone.0262955.g001" ref-type="fig">Fig 1</xref>). This single-arm open-label trial was registered on clinicaltrials.gov as NCT03578003 and presented in accordance with the CONSORT extension for pilot and feasibility trials guidelines [<xref rid="pone.0262955.ref048" ref-type="bibr">48</xref>–<xref rid="pone.0262955.ref050" ref-type="bibr">50</xref>].</p>
              <fig position="float" id="pone.0262955.g001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <title>CONSORT diagram.</title>
                  <p>The CONSORT diagram outlining the recruitment, flow, data processing and final <italic toggle="yes">n</italic>’s for select key outcome measures.</p>
                </caption>
                <graphic xlink:href="pone.0262955.g001" position="float"/>
              </fig>
              <sec id="sec003">
                <title>Overview</title>
                <p>All subjects followed an identical protocol in this single-arm, open-label study. The baseline period was 7-days, where subjects were instructed to not alter their normal daily routine, including their sleep-wake schedule. Following this, subjects were instructed to receive 60-minutes of bright light therapy (LightPad Mini, Aurora Light Solutions Inc., Reno, NV, USA) every day for 28 consecutive days. Self-report questionnaires were administered pre- and post-intervention, and wrist actigraphy (Actiwatch-2, Philips Respironics, Bend, OR, USA) was collected continuously (35-days). Daily study diaries noting bedtime, wake time, daytime naps, prolonged nocturnal awakenings (&gt;15–30 minutes), and the timing/duration of light therapy were recorded.</p>
              </sec>
              <sec id="sec004">
                <title>Light therapy</title>
                <p>Study personnel provided verbal and visual explanation of how to set-up and turn on/off the lightbox, including correctly positioning the distance (no further than 25-inches), angle (~45°) and pitch (variable) relative to the subject’s face, increasing the intensity to its maximum level, and personalizing use of the device based on subjects’ home configurations. Subjects were permitted to engage in specific activities that did not require them to move away from the lightbox or otherwise avert their eyes or substantially change the direction of their gaze. These activities principally included using a computer or reading. The Aurora LightPad Mini, per the manufacturer and confirmed by our own independent photometer assessments (Dr.meter LX1010B, London, England), produced up to 10,000 lux at the eye, at a distance of 25-inches. Thus, subjects were instructed to keep the lightbox no less than 25-inches from their face. A printed infographic illustrating the above points was attached to each lightbox for constant reinforcement.</p>
              </sec>
              <sec id="sec005">
                <title>Light validation and reporting</title>
                <p>In line with guidance on reporting light exposure in human chronobiology and sleep research studies,[<xref rid="pone.0262955.ref051" ref-type="bibr">51</xref>] we characterized the spectral power distributions (SPD) and illuminance reaching the eye of the participants when using the Aurora LightPad Mini (<xref rid="pone.0262955.t001" ref-type="table">Table 1</xref>). SPDs were recorded using a calibrated spectrophotometer (Konica Minolta, CL-500A Spectrophotometer, NJ, USA; calibrated on 09/09/2019), after allowing the lightbox 10-minutes for warm-up. Spectral radiance measurements were at a distance of 6-inches from the light source, an appropriate distance given the size of the LED light source (5.25” H x 7.5” L; 10x18 LED array), to minimize the influence of reflected light on the SPD measurement. Spectral irradiance estimates were made in an idealized set-up representing how subjects were instructed to position the lightbox, e.g., keeping it at an ~45° angle relative to their field of vision, and angled toward their eyes (generally upward). Ambient light was minimized during these measurements to characterize the output/stimulus provided by the lightbox. Illuminance was recorded using a calibrated illuminance meter (Konica Minolta, T-10A Illuminance Meter, NJ, USA; calibrated 12/17/2018) at a distance of 25-inches reflecting the maximum distance communicated to subjects in dark ambient conditions. The lightbox was positioned at the edge of a table to minimize any reflections off other surfaces before the light reached the detecting source. This series of SPD and illuminance measurements was made on three different lightboxes, with data presented as a group average (<xref rid="pone.0262955.s002" ref-type="supplementary-material">S1 Table</xref>).</p>
                <table-wrap position="float" id="pone.0262955.t001">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Aurora LightPad Mini characteristics.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0262955.t001" id="pone.0262955.t001g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Properties</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Photopic: ƛ<sub>max</sub>, (nm) and illuminance (lux)</td>
                          <td align="center" rowspan="1" colspan="1">555 and 8,763</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Irradiance (W/m<sup>2</sup>)</td>
                          <td align="center" rowspan="1" colspan="1">28.66</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Log photon irradiance/s/m<sup>2</sup></td>
                          <td align="center" rowspan="1" colspan="1">19.89</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">S-cone: ƛ<sub>max</sub> (nm) and ɑ-opic (W/m<sup>2</sup>)</td>
                          <td align="center" rowspan="1" colspan="1">419 and 7.01</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">M-cone: ƛ<sub>max</sub> (nm) and ɑ-opic (W/m<sup>2</sup>)</td>
                          <td align="center" rowspan="1" colspan="1">531 and 12.47</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">L-cone: ƛ<sub>max</sub> (nm) and ɑ-opic (W/m<sup>2</sup>)</td>
                          <td align="center" rowspan="1" colspan="1">558 and 14.16</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Rhodopic: ƛ<sub>max</sub> (nm) and ɑ-opic (W/m<sup>2</sup>)</td>
                          <td align="center" rowspan="1" colspan="1">496 and 11.73</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Melanopic: ƛ<sub>max</sub> (nm) and ɑ-opic (W/m<sup>2</sup>)</td>
                          <td align="center" rowspan="1" colspan="1">480 and 10.50</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Peak Wavelength, nm</td>
                          <td align="center" rowspan="1" colspan="1">455</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Chromaticity, x/y</td>
                          <td align="center" rowspan="1" colspan="1">0.314, 0.329</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec006">
                <title>Actigraphy</title>
                <p>Wrist actigraphy was continuously collected in 2-min epochs for all 35-days. Subjects wore the actiwatch on their non-dominant wrist. Ensuring the photometer was exposed to the light source during treatment (e.g., not under long sleeves, not underneath a table, in a pocket, or otherwise obstructed) was a particular priority. While light detection at the wrist is not the same as light detection at the retina, it provides a crude estimate of adherence, as well as the timing and dose of subject’s light exposure. Actigraphy data were analyzed using the Actiware version 6.0.9 proprietary algorithm (Philips Respironics, Bend, OR, USA) with the activity threshold set to “medium”. Actigraphy based outcomes have been validated against in-lab polysomnography [<xref rid="pone.0262955.ref052" ref-type="bibr">52</xref>]. Each study day, from 12:00 PM to 11:58 AM was analyzed individually for bedtime, sleep onset, wake time, mid-sleep time, total sleep time (TST), time in bed (TIB), sleep onset latency (SOL), sleep efficiency (SE), wake after sleep onset (WASO), total activity, average activity/epoch, and number of nocturnal awakenings. Actigraphy metrics came from data averaged across 3–5 consecutive final days before the pre- and post-intervention assessments. To minimize heterogeneity within subjects, sleep diaries were examined for days where subjects reported not working, working aberrant schedules, or when ill or traveling; these periods were excluded from analyses. On average, the aforementioned sleep diary assessment resulted in excluding 1–2 days over the 35-day study period per subject.</p>
              </sec>
              <sec id="sec007">
                <title>Questionnaires</title>
                <sec id="sec008">
                  <title>Sleep</title>
                  <p>Sleep quality outcomes consisted of the Insomnia Severity Index (ISI) and the Sleep Hygiene Index (SHI). Together these assessments probe difficulty initiating and maintaining sleep, and common behavioral habits contributing to sleep disruption. The ISI is a 7-item measure, each item a 5-point Likert scale [<xref rid="pone.0262955.ref053" ref-type="bibr">53</xref>,<xref rid="pone.0262955.ref054" ref-type="bibr">54</xref>]. The SHI is a 13-item measure, each item a 5-point Likert [<xref rid="pone.0262955.ref055" ref-type="bibr">55</xref>].</p>
                </sec>
                <sec id="sec009">
                  <title>TBI and PTSD</title>
                  <p>TBI-relevant outcomes were the Neurobehavioral Symptom Inventory (NSI) and the PTSD checklist for DSM-5 (PCL-5). The NSI assesses TBI relevant symptom severity over the past 2-weeks, and is composed of 22-items, each a 5-point Likert scale [<xref rid="pone.0262955.ref056" ref-type="bibr">56</xref>–<xref rid="pone.0262955.ref058" ref-type="bibr">58</xref>]. The PCL-5 is used for screening/provisional diagnosis of PTSD, and assessing symptom severity over the 30-days using 20-items, each a 5-point Likert [<xref rid="pone.0262955.ref059" ref-type="bibr">59</xref>]. The total score can be subdivided into four subscales or “clusters”: Cluster B (intrusion), cluster C (avoidance), cluster D (mood/cognition), and cluster E (arousal). PTSD was determined by a total score ≥33 and meeting “cluster criteria”, as before [<xref rid="pone.0262955.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0262955.ref008" ref-type="bibr">8</xref>], requiring subjects to rate one B item, one C item, two D items, and two E items as 2 (“moderately”) or higher [<xref rid="pone.0262955.ref059" ref-type="bibr">59</xref>].</p>
                </sec>
                <sec id="sec010">
                  <title>Mood</title>
                  <p>Metrics related to mood were derived from the Patient Health Questionnaire (PHQ-9) and NIH PROMIS Emotional-Distress and Anxiety (EDA) short-form 4a. The PHQ-9 assesses mood and depression severity over the previous 2-weeks. It is 9-items, each a 4-point Likert scale. The EDA comes from the NIH PROMIS catalog and assesses anxiety severity over the past 7-days. It is composed of 4-items, each a 5-point Likert scale.</p>
                </sec>
                <sec id="sec011">
                  <title>Pain</title>
                  <p>Metrics of pain come from the NIH PROMIS Pain Interference short-form 4a and the Pain Intensity short-form 3a, assessing perceived pain over the past 7-days. Pain Interference is composed of 4-items, each a 5-point Likert scale. Pain intensity is composed of 3-items, each a 5-point Likert scale.</p>
                </sec>
                <sec id="sec012">
                  <title>Quality of life</title>
                  <p>The World Health Organization Disability Assessment Schedule (WHO-DAS 2.0) assesses general health and disability in major life domains following the conceptual framework for the International Classification of Functioning, Disability, and Health over the past 30-days. It is composed of 12-items, each a 5-point Likert scale.</p>
                </sec>
              </sec>
              <sec id="sec013">
                <title>Blood-based biomarkers</title>
                <p>Whole blood was collected pre- and post-intervention (i.e., generally day 1 and 35 of the protocol, corresponding to the beginning of baseline and end of intervention), immediately inverted 10x and stored at 4°C until processing for plasma and serum (~1–3 hours). Aliquots were stored at -80°C until a sufficient number was obtained for batch assays. Plasma samples were sent to the NIH NINR Biomarker Core Laboratory (PI: J.M.G.) for 4-plex and 3-plex immunoassays (exploratory outcomes) using an ultrasensitive single-molecule enzyme-linked immunosorbent assay via Simoa<sup>™</sup> technology (Quanterix, Lexington, MA, USA) [<xref rid="pone.0262955.ref060" ref-type="bibr">60</xref>–<xref rid="pone.0262955.ref062" ref-type="bibr">62</xref>]. The 4-plex measured concentrations of glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), tau, and ubiquitin C-terminal hydrolase-L1 (UCHL1) [<xref rid="pone.0262955.ref063" ref-type="bibr">63</xref>]. The 3-plex measured concentrations of interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-ɑ).</p>
                <p>Of the <italic toggle="yes">n</italic> = 33 subjects, pre- and post-blood samples were obtained in <italic toggle="yes">n</italic> = 25 subjects. For the 4-plex assay, a final <italic toggle="yes">n</italic> = 13 was used (12-subjects excluded due to either unreadable results (<italic toggle="yes">n</italic> = 3 to 5 per assay), data not being obtained in duplicate (<italic toggle="yes">n</italic> = 7 to 8 per assay), or having a coefficient of variance &gt;15% (<italic toggle="yes">n</italic> = 2 to 3 per assay) (<xref rid="pone.0262955.g001" ref-type="fig">Fig 1</xref>). UCHL1 was detectable for only 4 subjects (2 of which were not obtained in duplicate), as such these UCLH1 data were excluded. No outliers were detected using the extreme studentized deviate analysis. For the 3-plex assay, a final sample size of <italic toggle="yes">n</italic> = 23 was used (2 subjects excluded due to meeting outlier criteria). The average coefficients of variance for the 4-plex and 3-plex assays were, 4.5±3.0% and 3.2±2.5%, respectively.</p>
              </sec>
              <sec id="sec014">
                <title>Statistical analysis</title>
                <p>Analyses were performed using GraphPad Prism v8.4.2. Alpha of 0.05, defined <italic toggle="yes">a priori</italic>, was used for all tests unless otherwise noted. Mean differences between pre- and post-intervention outcomes were assessed via paired, two-tailed t-tests. Pearson <italic toggle="yes">r</italic> correlation coefficient, and corresponding confidence intervals, were analyzed comparing the percent improvement in ISI score (primary outcome) to ancillary outcome measures (<italic toggle="yes">Questionnaires</italic>: SHI, PCL-5, NSI, PHQ-9, EDA, Pain intensity, Pain interference, WHO-DAS 2.0. 2. <italic toggle="yes">Actigraphy</italic>: TST, TIB, SE, WASO, SOL. <italic toggle="yes">Blood-based biomarkers</italic>: GFAP, NfL, tau, IL-6, IL-10, TNF- ɑ). Subsequently, exploratory multiple linear regression analyses were performed to parse out the most impactful contributing variables to subjects percent improvement in ISI score. Models included 1) all questionnaires with a significant post-intervention change, 2) significant actigraphy derived metrics, and 3) significant blood-based biomarker changes (including additional combinations of models encompassing all variables, and models with hierarchal inclusion). As a final measure of association, the odds ratio was used. These models were strictly exploratory and should be interpreted as such.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec015">
              <title>Results</title>
              <p>Demographic and TBI-related data are presented in <xref rid="pone.0262955.t002" ref-type="table">Table 2</xref>. This population was predominantly middle-aged, male, white, with at least some college education, and on average exercised &gt;90-minutes/week. All subjects were in the chronic phase of TBI recovery (range: 3–55 years post-injury), with 78% reporting 1–3 TBIs over their lifetime. Forty-two percent of subjects incurred their injury through active military combat. Causes of TBI ranged from blast exposure, blunt force, falling, and motor vehicle or sports-related accidents. Self-reported location of injury was unknown or via blast exposure in 8 subjects, and otherwise determined to be in the frontal (<italic toggle="yes">n</italic> = 7), right temporal (<italic toggle="yes">n</italic> = 3), right parietal (<italic toggle="yes">n</italic> = 2), left parietal (<italic toggle="yes">n</italic> = 3) and occipital (<italic toggle="yes">n</italic> = 10) region. A total of 12 subjects reported loss of consciousness, and 11 subjects reported some degree of post-traumatic amnesia, however, all injuries were determined to be of mild severity (i.e., mTBI). PTSD was present in 18 (54%) subjects.</p>
              <table-wrap position="float" id="pone.0262955.t002">
                <object-id pub-id-type="doi">10.1371/journal.pone.0262955.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>Demographic and TBI related variables.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0262955.t002" id="pone.0262955.t002g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <italic toggle="yes">n</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">33</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age, years</td>
                        <td align="center" rowspan="1" colspan="1">53 ± 18</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sex, male</td>
                        <td align="center" rowspan="1" colspan="1">30 (91%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Race, white</td>
                        <td align="center" rowspan="1" colspan="1">25 (76%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Education, ≥some college</td>
                        <td align="center" rowspan="1" colspan="1">28 (85%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Exercise, &gt;90 min/week</td>
                        <td align="center" rowspan="1" colspan="1">23 (70%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">TBI recency, years</td>
                        <td align="center" rowspan="1" colspan="1">26 ± 17</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">TBI recency range, years</td>
                        <td align="center" rowspan="1" colspan="1">3–55</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Number of TBIs</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 1</td>
                        <td align="center" rowspan="1" colspan="1">12 (36%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 2–3</td>
                        <td align="center" rowspan="1" colspan="1">14 (42%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 4–5</td>
                        <td align="center" rowspan="1" colspan="1">4 (12%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> &gt;5</td>
                        <td align="center" rowspan="1" colspan="1">3 (10%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Type</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Blast</td>
                        <td align="center" rowspan="1" colspan="1">4 (12%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Blunt force</td>
                        <td align="center" rowspan="1" colspan="1">6 (18%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Fall</td>
                        <td align="center" rowspan="1" colspan="1">12 (36%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Sports/MVC</td>
                        <td align="center" rowspan="1" colspan="1">9 (27%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Unknown</td>
                        <td align="center" rowspan="1" colspan="1">2 (6%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Loss of consciousness</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> None</td>
                        <td align="center" rowspan="1" colspan="1">18 (55%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> &lt;30 seconds</td>
                        <td align="center" rowspan="1" colspan="1">6 (18%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 1–5 minutes</td>
                        <td align="center" rowspan="1" colspan="1">5 (15%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> &gt;5 minutes</td>
                        <td align="center" rowspan="1" colspan="1">1 (3%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Post-traumatic amnesia, yes</td>
                        <td align="center" rowspan="1" colspan="1">11 (33%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Sleep medication, yes</td>
                        <td align="center" rowspan="1" colspan="1">17 (51%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Pain medication, yes</td>
                        <td align="center" rowspan="1" colspan="1">19 (56%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">PTSD, yes</td>
                        <td align="center" rowspan="1" colspan="1">18 (54%)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t002fn001">
                    <p>Data are mean ± SD, or <italic toggle="yes">n</italic> (%). TBI, traumatic brain injury; PTSD, post-traumatic stress disorder. Sleep medication includes any of the following: Sedative-hypnotics, benzodiazepines, gamma-hydroxybutyric acid, doxylamine, trazadone, quetiapine, diphenhydramine, mirtazapine, and over the counter herbs. Pain medication includes any of the following: Oxycontin, hydrocodone, morphine, oxycodone, hydrocodone bitartrate, fentanyl patch, methadone, codeine, naltrexone/suboxone, and lidocaine patch.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="sec016">
                <title>Acceptability, feasibility, and adherence</title>
                <p>Of the 33 subjects, 22 (67%) reported liking the lightbox, 8 (24%) reported not liking the lightbox, and 3 (9%) neither liked nor disliked the lightbox. Reasons for not liking the lightbox were predominantly due to the light being too bright and/or the light disturbing other people in the subject’s household. Similarly, 22 (67%) of subjects reported liking wearing the actiwatch, 5 (15%) reported not liking wearing the actiwatch and 6 (18%) neither liked nor disliked wearing the actiwatch. Reasons for not liking the actiwatch were primarily because of discomfort/annoyance.</p>
                <p>With respect to treatment feasibility and adherence, 30 (91%) subjects reported using the lightbox 5–7 days/week. Two subjects reported using the lightbox 3–4 days/week, and 1 subject reported using the lightbox 1–2 days/week. Average percent adherence based off of subjects reported daily usage (time of day/duration) logged in their sleep diary was 83% (range: 43%-100%; 29 subjects were &gt;74%). In the majority of cases, photometer data aligned with self-reported use of the lightbox. Discrepancies are assumed to be due to user error (e.g., sleeves covering wrist or watch not facing the lightbox). For the actiwatch, 32 (97%) of subjects reported wearing it 7 days/week and only <italic toggle="yes">n</italic> = 1 subject reported wearing it 5–6 days/week. In general, this closely aligned with subjects’ objective data.</p>
              </sec>
              <sec id="sec017">
                <title>Sleep</title>
                <p>ISI scores improved following light therapy (<xref rid="pone.0262955.g002" ref-type="fig">Fig 2</xref>) without a concomitant change in SHI. Subjects ISI score decreased by 23% (14.8±5.9 to 11.4±4.7; <italic toggle="yes">p</italic>&lt;0.0001), clinically corresponding to a change of “moderate” to “mild” insomnia. Pre and post-SHI scores were unchanged (18.1±7.1 to 18.0±6.2; <italic toggle="yes">p</italic> = 0.97).</p>
                <fig position="float" id="pone.0262955.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Sleep related questionnaire data.</title>
                    <p>Pre- and post-morning bright light therapy questionnaire scores for the (<bold>A</bold>) Sleep Hygiene Index (SHI; range = 0–52; higher = worse sleep hygiene) and (<bold>C</bold>) Insomnia Severity Index (ISI; range = 0–28; higher = worse insomnia) displayed as truncated violin plots with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) SHI and (<bold>D</bold>) ISI, normalized to the maximum score of each questionnaire, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g002" position="float"/>
                </fig>
                <p>Objective actigraphic outcomes (<xref rid="pone.0262955.t003" ref-type="table">Table 3</xref>) were consistent with these self-report metrics, with an average improvement in TST of 47-minutes (5:33±1:07 to 6:22±1:13; <italic toggle="yes">p</italic> = 0.004), corresponding to an average increase in TIB of 59-minutes (6:40±1:04 to 7:39±1:13; <italic toggle="yes">p</italic> = 0.001). Normalizing these metrics to individual durations show a 21.2%±27.5% increase in TST, and a 16.3%±19.6% increase in TIB. Other metrics, including SE, WASO, SOL, activity, and the number of nocturnal awakenings were unchanged. The increase in TST and TIB came from subjects shifting their bedtime earlier, by an average of 77-minutes (00:04±1:36 to 22:47±4:24; <italic toggle="yes">p</italic> = 0.001). Waketimes averaged 30-minutes earlier, though this change was not statistically significant (<italic toggle="yes">p</italic> = 0.061), but were found to be more regular (i.e., less variable; p = 0.022). Mid-sleep times were also shifted earlier by an average of 37-minutes (3:13±1:15 to 2:36±1:31; <italic toggle="yes">p</italic> = 0.003).</p>
                <table-wrap position="float" id="pone.0262955.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Actigraphy metrics pre- and post-morning bright light therapy.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0262955.t003" id="pone.0262955.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Pre</th>
                          <th align="center" rowspan="1" colspan="1">Post</th>
                          <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Bedtime, hh:mm</td>
                          <td align="center" rowspan="1" colspan="1">00:04 ± 1:36</td>
                          <td align="center" rowspan="1" colspan="1">22:47 ± 4:24</td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.001</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Waketime, hh:mm</td>
                          <td align="center" rowspan="1" colspan="1">6:52 ± 1:22</td>
                          <td align="center" rowspan="1" colspan="1">6:22 ± 1:37</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.061</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Mid-sleep time, hh:mm</td>
                          <td align="center" rowspan="1" colspan="1">3:13 ± 1:15</td>
                          <td align="center" rowspan="1" colspan="1">2:36 ± 1:31</td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.003</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Time in bed, hh:mm</td>
                          <td align="center" rowspan="1" colspan="1">6:40 ± 1:04</td>
                          <td align="center" rowspan="1" colspan="1">7:39 ± 1:13</td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.001</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">TST, hh:mm</td>
                          <td align="center" rowspan="1" colspan="1">5:33 ± 1:07</td>
                          <td align="center" rowspan="1" colspan="1">6:22 ± 1:15</td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.004</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SOL, min</td>
                          <td align="center" rowspan="1" colspan="1">5.4 ± 5.4</td>
                          <td align="center" rowspan="1" colspan="1">6.7 ± 8.2</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.597</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">SE, min</td>
                          <td align="center" rowspan="1" colspan="1">82.8 ± 8.4</td>
                          <td align="center" rowspan="1" colspan="1">83.3 ± 7.7</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.713</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">WASO, min</td>
                          <td align="center" rowspan="1" colspan="1">49.2 ± 23.6</td>
                          <td align="center" rowspan="1" colspan="1">59.5 ± 31.7</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.061</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Total Activity, units</td>
                          <td align="center" rowspan="1" colspan="1">204091 ± 72912</td>
                          <td align="center" rowspan="1" colspan="1">210932 ± 47386</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.278</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Avg AC/epoch</td>
                          <td align="center" rowspan="1" colspan="1">459.0 ± 177.0</td>
                          <td align="center" rowspan="1" colspan="1">531.5 ± 107.0</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.634</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Awakenings, #</td>
                          <td align="center" rowspan="1" colspan="1">12.3 ± 5.0</td>
                          <td align="center" rowspan="1" colspan="1">13.1 ± 3.6</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.452</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Light exposure, lux-min</td>
                          <td align="center" rowspan="1" colspan="1">250 ± 204.7</td>
                          <td align="center" rowspan="1" colspan="1">38910.3 ± 36180.5</td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.005</bold>
                          </td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>Data are mean ± SD. TST, total sleep time; SOL, sleep onset latency; SE, sleep efficiency; WASO, wake after sleep onset; AC, activity counts. Data were analyzed via paired students t-test. * = <italic toggle="yes">p</italic> &lt;0.05 versus Pre.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="sec018">
                <title>TBI-related symptoms</title>
                <p>Subjects reported improvements in both the NSI and PCL-5 (<xref rid="pone.0262955.g003" ref-type="fig">Fig 3</xref>). NSI scores were reduced by 16% (32.5±17.0 to 27.2±16.4; <italic toggle="yes">p</italic> = 0.013), and PCL-5 scores were reduced by 18% (35.8±19.9 to 29.5±18.2; <italic toggle="yes">p</italic> = 0.025). The percent improvement in ISI scores was positively correlated with subjects’ percent improvement in both the NSI (<italic toggle="yes">r</italic> = 0.39; CI = 0.05–0.66; <italic toggle="yes">p</italic> = 0.028), and PCL-5 (<italic toggle="yes">r</italic> = 0.69; CI = 0.44–0.84; <italic toggle="yes">p</italic>&lt;0.0001). Additionally, percent improvement in ISI was also negatively correlated with subjects’ baseline PCL-5 score, i.e., worse PTSD symptom severity predicted greater improvement in ISI scores (<italic toggle="yes">r</italic> = -0.41; CI = -0.67–0.07; <italic toggle="yes">p</italic> = 0.021).</p>
                <fig position="float" id="pone.0262955.g003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>TBI-related symptom severity.</title>
                    <p>Pre- and post-morning bright light therapy questionnaire scores for the (<bold>A</bold>) Neurobehavioral Symptom Inventory (NSI; range = 0–88; higher = worse brain injury related symptom severity) and (<bold>C</bold>) Post-traumatic stress disorder (PTSD) checklist-5 (PCL-5; range = 0–80; higher = worse PTSD symptom severity) displayed as truncated violin plots with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) NSI and (<bold>D</bold>) PCL-5 normalized to the maximum score of each questionnaire, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g003" position="float"/>
                </fig>
              </sec>
              <sec id="sec019">
                <title>Mood symptoms</title>
                <p>Both the PHQ-9 and EDA scale showed significant improvements (<xref rid="pone.0262955.g004" ref-type="fig">Fig 4</xref>). PHQ-9 scores decreased by 27% (11.9±8.0 to 8.6±6.6; <italic toggle="yes">p</italic> = 0.003), and EDA scores decreased by 12.7% (10.2±4.9 to 8.9±4.0; <italic toggle="yes">p</italic> = 0.021). Percent improvement in ISI was positively correlated with percent improvement in PHQ-9 (<italic toggle="yes">r</italic> = 0.55; CI = 0.22–0.76; <italic toggle="yes">p</italic> = 0.002), but not with percent improvement in EDA.</p>
                <fig position="float" id="pone.0262955.g004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Mood and anxiety.</title>
                    <p>Pre- and post-morning bright light therapy questionnaire scores for the (<bold>A</bold>) Patient Health Questionnaire-9 (PHQ-9; range = 0–27; higher = worse depressive symptom severity) and (<bold>C</bold>) NIH PROMIS Emotional-Distress and Anxiety (EDA; range 4–20; higher = worse symptom severity) displayed as truncated violin plots with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) PHQ-9 and (<bold>D</bold>) EDA normalized to the maximum score of each questionnaire, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g004" position="float"/>
                </fig>
              </sec>
              <sec id="sec020">
                <title>Pain symptoms</title>
                <p>No changes were reported in pain intensity (9.0±2.9 to 8.6±2.8; <italic toggle="yes">p</italic> = 0.24); however, subjects did show a significant reduction in pain interference (12.8±5.2 to 11.2±4.9; <italic toggle="yes">p</italic> = 0.031), corresponding to a decrease of 12.5% (<xref rid="pone.0262955.g005" ref-type="fig">Fig 5</xref>). This dissociation between pain intensity and interference (e.g., ability to cope with intensity) is of particular interest as it emphasizes a role for light therapy and improved sleep on functional outcomes, rather than changes to the fundamental biology of nociception. No significant correlations between pain intensity or interference with subject’s percent change in ISI were observed.</p>
                <fig position="float" id="pone.0262955.g005">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g005</object-id>
                  <label>Fig 5</label>
                  <caption>
                    <title>Pain interference and intensity.</title>
                    <p>Pre- and post-morning bright light therapy questionnaire scores for the (<bold>A</bold>) NIH PROMIS Pain Interference (range = 4–20; higher = worse pain interference) and (<bold>C</bold>) NIH PROMIS Pain Intensity (range = 3–15; higher = pain intensity) displayed as truncated violin plots with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) pain interference and (<bold>D</bold>) pain intensity, normalized to the maximum score of each questionnaire, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g005" position="float"/>
                </fig>
              </sec>
              <sec id="sec021">
                <title>Quality of life</title>
                <p>Subjects reported a significant improvement in the WHO-DAS 2.0 (<xref rid="pone.0262955.g006" ref-type="fig">Fig 6</xref>), corresponding to a decrease of 17.7% (36.2%±21.5% to 29.8%±21.8%; <italic toggle="yes">p</italic> = 0.005). No significant correlation between WHO-DAS with subject’s percent change in ISI was found.</p>
                <fig position="float" id="pone.0262955.g006">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g006</object-id>
                  <label>Fig 6</label>
                  <caption>
                    <title>Quality of life.</title>
                    <p>Pre- and post-morning bright light therapy questionnaire scores for the (<bold>A</bold>) World Health Organization Disability Assessment Schedule 2.0 (WHO-DAS 2.0; range = 0–100%; higher = worse quality of life/greater disability) is displayed as a truncated violin plot with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) WHO-DAS 2.0 is normalized to the maximum score of this questionnaire, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g006" position="float"/>
                </fig>
              </sec>
              <sec id="sec022">
                <title>Blood-based biomarkers</title>
                <p>Changes in plasma biomarkers related to peripheral markers of neuronal injury/neuroinflammation and inflammation were assessed as exploratory outcomes. No differences pre- and post-intervention were observed for GFAP, NfL, and tau (<xref rid="pone.0262955.g007" ref-type="fig">Fig 7</xref>); however, trends were detected in NfL showing a decrease of 13.2% (12.1±11.4 to 10.5±9.8; <italic toggle="yes">p</italic> = 0.064), and tau showing a decrease of 17.4% (2.3±0.6 to 1.9±0.7; <italic toggle="yes">p</italic> = 0.103). The pro-inflammatory cytokines IL-6 (2.2±0.8 to 1.8±0.7; <italic toggle="yes">p</italic> = 0.028) and TNF-ɑ (3.1±1.4 to 2.9±1.4; <italic toggle="yes">p</italic> = 0.037) were significantly reduced by 14.5% and 5.7%, respectively, following light therapy (<xref rid="pone.0262955.g008" ref-type="fig">Fig 8</xref>). The anti-inflammatory cytokine IL-10 was unchanged (0.6±0.2 to 0.7±0.3; <italic toggle="yes">p</italic> = 0.43). Percent change in ISI was positively correlated with subject’s percent change in IL-6 (<italic toggle="yes">r</italic> = 0.43; CI = 0.02–0.72; <italic toggle="yes">p</italic> = 0.043), but not with percent change in TNF-ɑ or IL-10.</p>
                <fig position="float" id="pone.0262955.g007">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g007</object-id>
                  <label>Fig 7</label>
                  <caption>
                    <title>Neuronal injury and neuroinflammation biomarkers.</title>
                    <p>Pre- and post-morning bright light therapy biomarkers for (<bold>A</bold>) Glial Fibrillary Acidic Protein (GFAP), (<bold>C</bold>) Neurofilament Light Chain (NfL), and (<bold>E</bold>) Tau, displayed as truncated violin plots with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) GFAP, (<bold>D</bold>) NfL, and (<bold>F</bold>) Tau, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g007" position="float"/>
                </fig>
                <fig position="float" id="pone.0262955.g008">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0262955.g008</object-id>
                  <label>Fig 8</label>
                  <caption>
                    <title>Peripheral cytokines.</title>
                    <p>Pre- and post-morning bright light therapy biomarkers for (<bold>A</bold>) Interleukin-6 (IL-6), (<bold>C</bold>) Tumor Necrosis Factor Alpha (TNF-ɑ), and (<bold>E</bold>) Interleukin-10 (IL-10) displayed as truncated violin plots with moderate smoothing (dashed line = median score; dotted lines = 25% and 75% quartiles). Percent change in each Individual for (<bold>B</bold>) IL-6, (<bold>D</bold>) TNF-ɑ, and (<bold>F</bold>) IL-10, plotted with the mean and standard deviation overlaid. Shaded symbols are subjects with co-morbid post-traumatic stress disorder (PTSD), open symbols are subjects without co-morbid PTSD. * = <italic toggle="yes">p</italic> &lt;0.05 vs pre; paired two-tail t-test.</p>
                  </caption>
                  <graphic xlink:href="pone.0262955.g008" position="float"/>
                </fig>
              </sec>
              <sec id="sec023">
                <title>Contribution of PTSD</title>
                <p>Due to the multiple significant correlations identified between percent change in ISI and changes in other self-report measures, multiple linear regression analyses were performed to determine which self-report measures had the largest contribution to these effects. Several models were examined, including a model containing all self-report questionnaires that showed significant changes post-intervention as predictor variables. In all models, percent change in PCL-5 was the sole significant predictor of improvement in ISI after light therapy (β = 0.586; <italic toggle="yes">p</italic> = 0.006).</p>
                <p>No significant effect of PTSD was found through multiple linear regression models of either blood-based biomarkers, or actigraphy derived metrics, in predicting subjects’ percent change in ISI score.</p>
                <p>To assess the association between change in ISI and PTSD, the odds ratio was calculated separating those without PTSD (<italic toggle="yes">n</italic> = 15) from those with PTSD (<italic toggle="yes">n</italic> = 18). When using a criterion of a ≥4-point decrease in ISI score to define response to light therapy, subjects with comorbid PTSD had 5.76 times the odds (CI: 1.18–28.28; <italic toggle="yes">p</italic> = 0.041) of showing a response to light therapy compared to subjects without PTSD. Although this association should be interpreted knowing that odds ratios are generally overestimated with smaller sample sizes, this association is also supported by the raw data. On average, subjects with co-morbid PTSD had higher pre-intervention ISI scores (<xref rid="pone.0262955.g002" ref-type="fig">Fig 2A</xref>; with PTSD, 17.1±5.3 vs without PTSD, 11.9±5.5), as well as a greater percent change post-intervention (<xref rid="pone.0262955.g002" ref-type="fig">Fig 2B</xref>; with PTSD, 15.1±16.9% vs without PTSD, 8.7±13.8%), corresponding to post-intervention ISI scores of 12.9±4.5 (TBI with PTSD) vs. 9.5±4.6 (TBI without PTSD). Based on these raw scores, subjects with PTSD shifted from “moderate” insomnia to “mild” insomnia, while those without PTSD remained in the “mild” category.</p>
              </sec>
              <sec id="sec024">
                <title>Harms</title>
                <p>There were no documented important harms or unintended effects throughout the course of this study.</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec025">
              <title>Discussion</title>
              <p>This single-arm, open-label feasibility study using morning bright light therapy in Veterans with TBI shows high patient acceptability, adherence, and preliminary efficacy on both subjective and objective sleep outcomes. Furthermore, downstream mechanisms potentially affected by poor sleep, including mood, pain and quality of life also showed improvement. Blood-based biomarkers showed improvements in IL-6 and TNF-ɑ, peripheral pro-inflammatory cytokines, and trends toward potential improvements in markers associated with neuronal injury and neuroinflammation (NfL and tau). Overall, these results support the rationale for a fully powered randomized controlled trial with longitudinal follow-up to more rigorously evaluate morning bright light therapy as an intervention in this patient population. Having an effective and acceptable intervention to improve sleep disturbances—a persistent and debilitating consequence of TBI—will be critical to adequately address disability and optimize rehabilitation in Veterans in the chronic phase of recovery from TBI.</p>
              <sec id="sec026">
                <title>Light therapy improved subjective and objective sleep</title>
                <p>Our results showed that both subjective (self-report surveys) and objective sleep (wrist based actigraphy) improved with morning bright light therapy. Although improvements in sleep following morning bright light therapy, either subjective or objective, have been reported, this is not a universal finding. A recent systematic review and meta-analysis on the effect of light therapy on sleep problems [<xref rid="pone.0262955.ref064" ref-type="bibr">64</xref>] highlights the importance of the type of sleep problem (e.g., insomnia, circadian rhythm disorders, dementia), the number of treatment days, the duration of treatment, and the age of subjects on determining whether or not a beneficial effect of light therapy is observed. This review incorporates data from 53 studies and via multivariate analyses show an overall hedges g effect size of 0.39 for <italic toggle="yes">all</italic> outcome variables across <italic toggle="yes">all</italic> sleep problems. Hedges g effect sizes shift to 0.41 and 0.47 for <italic toggle="yes">all</italic> outcome variables, when only including studies on circadian rhythm sleep disorders (<italic toggle="yes">n</italic> = 15 studies) and insomnia (<italic toggle="yes">n</italic> = 15 studies), respectively. This review did not discuss the alignment/concordance across subjective and objective sleep outcomes within studies, but it is known that this is also an inconsistent finding in the literature. Alignment between subjective and objective sleep outcomes in the present study lends validity to the potential positive effect of light therapy on sleep in this population. Mean pre-ISI scores were ~15 and decreased to ~11 post-intervention, corresponding to a baseline diagnosis of moderate insomnia (15–21) improving to mild insomnia (8–14).</p>
                <p>Using actigraphy as a long-term objective measure of sleep is a strength of the study but brought challenges to implementation and data analysis. For example, employed subjects had variable schedules, which was addressed by manually curating ~5 consecutive days consistent with each subject’s workweek. We found the photometer on the actiwatch an unreliable indicator for lightbox usage. This was likely due to variability in distance and placement of the wrist from the lightbox, and whether subjects’ long-sleeved clothing or other material inadvertently obscured the photometer. Nevertheless, our data indicate the photometer was able to detect higher levels of light in the intervention period compared to the baseline.</p>
              </sec>
              <sec id="sec027">
                <title>Potential mechanisms of light therapy to improve sleep</title>
                <p>Seminal work identified a role for light in melatonin suppression [<xref rid="pone.0262955.ref065" ref-type="bibr">65</xref>,<xref rid="pone.0262955.ref066" ref-type="bibr">66</xref>] and since then, research has focused on the effect of light on shifting circadian rhythms [<xref rid="pone.0262955.ref067" ref-type="bibr">67</xref>]. More recent work has identified a role for light in improving depression, with animal models pointing to mechanisms related to direct neuronal projections from non-vision-forming pathways to limbic regions of the brain [<xref rid="pone.0262955.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0262955.ref031" ref-type="bibr">31</xref>,<xref rid="pone.0262955.ref068" ref-type="bibr">68</xref>,<xref rid="pone.0262955.ref069" ref-type="bibr">69</xref>]. Few studies have found morning bight light therapy effects on sleep directly, although this has not been studied to the extent of the circadian and mood fields [<xref rid="pone.0262955.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0262955.ref070" ref-type="bibr">70</xref>]. Some possibilities include light may have direct effects on brain regions involved in sleep (e.g., direct inhibition of the ventrolateral preoptic area), or maintenance of alertness, through the same melanopsin-dependent, non-image forming pathways as circadian rhythms and mood [<xref rid="pone.0262955.ref071" ref-type="bibr">71</xref>]. Increased alertness throughout the day may increase homeostatic sleep drive in the evening and help to consolidate nighttime sleep [<xref rid="pone.0262955.ref072" ref-type="bibr">72</xref>]. Alternatively, given the known bidirectional relationship between sleep and depression [<xref rid="pone.0262955.ref073" ref-type="bibr">73</xref>], it is also possible that light-induced mood improvement may indirectly improve sleep [<xref rid="pone.0262955.ref031" ref-type="bibr">31</xref>].</p>
                <p>This study was not designed to examine the underlying mechanisms of light therapy’s effects on sleep, but could potentially inform mechanistic-based hypotheses. Although this study did not assay melatonin to determine subjects dim light melatonin onset (DLMO; gold standard for assessing a shift in circadian rhythm), subjects mid-sleep times were determined via actigraphy which may be an acceptable surrogate to DLMO in estimating circadian shifts [<xref rid="pone.0262955.ref074" ref-type="bibr">74</xref>,<xref rid="pone.0262955.ref075" ref-type="bibr">75</xref>]. Morning bright light therapy shifted mid-sleep time by an average of 37-minutes, indicating a possible circadian mechanism. However, shifting bedtimes earlier (e.g., advancing circadian phase) may not necessarily increase total sleep time, which was observed. Therefore, while circadian phase advancement may contribute toward improvements in ISI, there are likely other factors as well. Of note, no subjects demonstrated clear evidence of any circadian rhythm sleep disorder on baseline actigraphy.</p>
              </sec>
              <sec id="sec028">
                <title>Light therapy and blood-based biomarkers</title>
                <p>A pipeline for smooth blood collection, processing, storage, and shipment to the NIH Core lab for assays was successfully established; however, we experienced substantial attrition of nearly half the samples with the 4-plex assay (<italic toggle="yes">n</italic> = 13). Furthermore, one of the 4 biomarkers in the 4-plex, UCHL1, was unable to be included in our analyses. However, NfL and tau are both widely accepted markers of neuronal injury [<xref rid="pone.0262955.ref060" ref-type="bibr">60</xref>,<xref rid="pone.0262955.ref076" ref-type="bibr">76</xref>,<xref rid="pone.0262955.ref077" ref-type="bibr">77</xref>]. Further, despite the small sample size, peripheral markers of neuronal injury and neuroinflammation such as NfL and tau still showed trends towards statistical significance in directions consistent with the existing literature.</p>
                <p>The 3-plex assay was much more robust, with the majority of the sample retained for analysis (<italic toggle="yes">n</italic> = 23 included). We found reductions in pro-inflammatory cytokines IL-6 and TNF-ɑ, and no change in the anti-inflammatory cytokine IL-10. These results are also consistent with existing literature, as other studies have reported improvements in pro-inflammatory cytokines with improved sleep, including treatment of sleep apnea [<xref rid="pone.0262955.ref060" ref-type="bibr">60</xref>,<xref rid="pone.0262955.ref078" ref-type="bibr">78</xref>].</p>
                <p>Of note, peripheral plasma does not reflect centrally circulating biomarkers. Future studies will explore brain-specific biomarkers, such as brain-derived exosomes containing tau and amyloid-β-42; promising markers in the neuropathology of TBI [<xref rid="pone.0262955.ref077" ref-type="bibr">77</xref>].</p>
              </sec>
              <sec id="sec029">
                <title>Contribution of PTSD to sleep and symptoms</title>
                <p>A common theme from this study, and other recent studies of TBI in the military population, is the importance of PTSD [<xref rid="pone.0262955.ref006" ref-type="bibr">6</xref>–<xref rid="pone.0262955.ref008" ref-type="bibr">8</xref>]. Multiple linear regression models in this study showing comorbid PTSD was the sole significant predictor for improved insomnia following light therapy. Additionally, individuals with TBI and comorbid PTSD had &gt;5 times the odds of showing an improvement in ISI score of at least 4-points. Given that the average baseline ISI score in this cohort was ~15 (i.e., moderate insomnia), a decrease in at least 4-points would reduce subjects to mild insomnia. This observation may be relevant for informing clinical decisions as to which subset of TBI patients may benefit the most from lightbox therapy.</p>
                <p>Recent work by Youngstedt <italic toggle="yes">et al</italic> [<xref rid="pone.0262955.ref042" ref-type="bibr">42</xref>] investigated the effect of light therapy on combat related PTSD in a population of 69 Veterans, using 10,000 lux for 30 min/day for 4 weeks. This study demonstrated no change in anxiety, depression or sleep (via subjective means or objective actigraphy), but did show improvements in PTSD symptom severity that were correlated with phase advancements in via actigraphy derived circadian rhythm assessments. Although the present study also demonstrated an improvement in PTSD symptom severity, these studies diverge in sleep specific outcomes. Methodologically, the Youngstedt et al study was placebo controlled but employed a treatment duration of 30 minutes (rather than 60 minutes in the present study) and used the Pittsburgh Sleep Quality Index (rather than the ISI for subjective sleep changes). The combination of the shorter treatment duration and different validated questionnaire, may in part, explain differences in sleep specific outcomes. It is also possible that there were differences between the study by Youngstedt et al and the present study in both the presence of comorbid TBI and the spectral content of the light source employed, both of which were not reported.</p>
              </sec>
              <sec id="sec030">
                <title>Limitations and further considerations</title>
                <p>This study evaluated a single dose (10,000 lux), duration (60 minutes daily for 4-weeks), and timing (morning) of light therapy. There have been a plethora of studies using many differing parameters of light therapy, and these are generally common parameter ranges [<xref rid="pone.0262955.ref064" ref-type="bibr">64</xref>]. However, many studies do not follow the recommended guidelines for reporting of light exposure [<xref rid="pone.0262955.ref051" ref-type="bibr">51</xref>], making it difficult to know the amount and spectral content of the light reaching the eye, and nearly impossible to accurately compare findings across studies. A strength of our study is the rigorous assessment of light exposure from our protocol (<xref rid="pone.0262955.s002" ref-type="supplementary-material">S1 Table</xref>; <bold>Supporting information</bold>). Additionally, accurately recording adherence to the light therapy is an inherent challenge to this intervention [<xref rid="pone.0262955.ref079" ref-type="bibr">79</xref>] and a strength to this study is collecting both self-reported adherence and an objective surrogate via the actiwatch luxometer. Taken together, adherence for ~90% of the population was very high (60 minutes; 5–7 days per week). Nevertheless, subjects with less-than-ideal adherence did not differ from those with “perfect” adherence, and incorporating adherence as a statistical covariate did not change any of the reported outcomes.</p>
                <p>This pilot study sought to determine the feasibility of conducting a larger clinical trial and as such, was not powered to detect treatment efficacy or changes in blood-based biomarker levels. While results support the feasibility, acceptability, and preliminary efficacy, including plasma biomarkers, conclusions cannot be made with regard to definitive mechanisms or directionality (e.g., sleep and mood, sleep and pain). Our data suggest advancing circadian phase to be a contributing factor, but secondary changes due to lights pleiotropic effects also likely contributed and cannot be ruled out. Instead of using mid-sleep time as a surrogate for circadian phase, serial serum or salivary melatonin collection to determine DLMO would be a more definitive biomarker with which to evaluate potential circadian effects. Actigraphy was collected and analyzed in 2 minute, rather than 1 minute, epochs (both of which are commonly reported in the literature [<xref rid="pone.0262955.ref080" ref-type="bibr">80</xref>]). An epoch duration of 2 minutes was chosen for the sake of preserving internal battery life and based on internal validation studies showing very little change in temporal resolution. Furthermore, because this study is single-arm and open-label, potential expectancy and/or placebo effects could not be determined, and the possibility remains that a change in daily routine, rather than the light therapy itself, improved sleep patterns. However, one piece of evidence arguing against this possibility is the lack of change in the Sleep Hygiene Index. Of note, approximately 50% of the subjects in this population reported use of sleep medications (no subjects reported melatonin usage). However, subjects did not change their sleep medication usage over the study period and no changes in statistical outcomes were found after controlling for medication usage.</p>
                <p>Overall, this study provides valuable process validation and contributes towards the design of an ongoing randomized, single-blinded, placebo-controlled clinical trial examining sleep, mood, pain, and biomarker outcome measures (NCT03968874, sponsored by the Department of Defense and the Center for Neuroscience and Regenerative Medicine; and NCT03785600, sponsored by the Department of Veteran Affairs, Rehabilitation Research and Development Service).</p>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec031">
              <title>Conclusion</title>
              <p>Morning bright light therapy was associated with improved sleep in Veterans with a history of mild TBI and showed high feasibility and moderate acceptability, as well as preliminary efficacy to improve other TBI sequela. Specific outcome measures improving post-light therapy included: subjective and objective sleep, symptoms related to TBI, PTSD, mood, and pain, and blood-based pro-inflammatory cytokines. Furthermore, comorbid PTSD significantly predicted improved insomnia post-light therapy. Overall, these results strongly support the rationale for a larger, blinded and placebo-controlled randomized clinical trial to more rigorously evaluate the efficacy of morning bright light therapy to improve sleep in Veterans with TBI.</p>
            </sec>
            <sec id="sec032" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0262955.s001" position="float" content-type="local-data">
                <label>S1 Checklist</label>
                <caption>
                  <title>CONSORT checklist.</title>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0262955.s001.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0262955.s002" position="float" content-type="local-data">
                <label>S1 Table</label>
                <caption>
                  <title>Spectral power distribution data.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0262955.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0262955.s003" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <title>Lim_4085_Protocol.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0262955.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors would like to express their sincere appreciation and gratitude for the participation of our research subjects, to the staff at the VAPORHCS Sleep Disorders Clinic, to Dr. Megan Callahan, PsyD for guidance on the TBI diagnostic interviews, and Cadence Michel for assistance in data collection.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0262955.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Hoge</surname><given-names>CW</given-names></name>, <name><surname>McGurk</surname><given-names>D</given-names></name>, <name><surname>Thomas</surname><given-names>JL</given-names></name>, <name><surname>Cox</surname><given-names>AL</given-names></name>, <name><surname>Engel</surname><given-names>CC</given-names></name>, <name><surname>Castro</surname><given-names>CA</given-names></name>. <article-title>Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq</article-title>. <source>N Engl J Med</source>. <year>2008</year>;<volume>358</volume>: <fpage>2543</fpage>–<lpage>2551</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa072972</pub-id>
<?supplied-pmid 18234750?><pub-id pub-id-type="pmid">18234750</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Ouellet</surname><given-names>M-C</given-names></name>, <name><surname>Savard</surname><given-names>J</given-names></name>, <name><surname>Morin</surname><given-names>CM</given-names></name>. <article-title>Insomnia following Traumatic Brain Injury: A Review</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2004</year>;<volume>18</volume>: <fpage>187</fpage>–<lpage>198</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1545968304271405</pub-id>
<?supplied-pmid 15669131?><pub-id pub-id-type="pmid">15669131</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Castriotta</surname><given-names>RJ</given-names></name>, <name><surname>Wilde</surname><given-names>MC</given-names></name>, <name><surname>Lai</surname><given-names>JM</given-names></name>, <name><surname>Atanasov</surname><given-names>S</given-names></name>, <name><surname>Masel</surname><given-names>BE</given-names></name>, <name><surname>Kuna</surname><given-names>ST</given-names></name>. <article-title>Prevalence and consequences of sleep disorders in traumatic brain injury</article-title>. <source>J Clin Sleep Med</source>. <year>2007</year>;<volume>3</volume>: <fpage>349</fpage>–<lpage>356</lpage>. <?supplied-pmid 17694722?><pub-id pub-id-type="pmid">17694722</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Duclos</surname><given-names>C</given-names></name>, <name><surname>Dumont</surname><given-names>M</given-names></name>, <name><surname>Wiseman-Hakes</surname><given-names>C</given-names></name>, <name><surname>Arbour</surname><given-names>C</given-names></name>, <name><surname>Mongrain</surname><given-names>V</given-names></name>, <name><surname>Gaudreault</surname><given-names>P-O</given-names></name>, <etal>et al</etal>. <article-title>Sleep and wake disturbances following traumatic brain injury</article-title>. <source>Pathol Biol</source>. <year>2014</year>;<volume>62</volume>: <fpage>252</fpage>–<lpage>261</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.patbio.2014.05.014</pub-id>
<?supplied-pmid 25110283?><pub-id pub-id-type="pmid">25110283</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Kempf</surname><given-names>J</given-names></name>, <name><surname>Werth</surname><given-names>E</given-names></name>, <name><surname>Kaiser</surname><given-names>PR</given-names></name>, <name><surname>Bassetti</surname><given-names>CL</given-names></name>, <name><surname>Baumann</surname><given-names>CR</given-names></name>. <article-title>Sleep-wake disturbances 3 years after traumatic brain injury</article-title>. <source>J Neurol Neurosurg Psychiatry</source>. <year>2010</year>;<volume>81</volume>: <fpage>1402</fpage>–<lpage>1405</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/jnnp.2009.201913</pub-id>
<?supplied-pmid 20884672?><pub-id pub-id-type="pmid">20884672</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Balba</surname><given-names>NM</given-names></name>, <name><surname>Elliott</surname><given-names>JE</given-names></name>, <name><surname>Weymann</surname><given-names>KB</given-names></name>, <name><surname>Opel</surname><given-names>RA</given-names></name>, <name><surname>Duke</surname><given-names>JW</given-names></name>, <name><surname>Oken</surname><given-names>BS</given-names></name>, <etal>et al</etal>. <article-title>Increased sleep disturbances and pain in Veterans with co-morbid TBI and PTSD</article-title>. <source>J Clin Sleep Med</source>. <year>2018</year>;<volume>14</volume>: <fpage>1865</fpage>–<lpage>1878</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5664/jcsm.7482</pub-id>
<?supplied-pmid 30373686?><pub-id pub-id-type="pmid">30373686</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Elliott</surname><given-names>JE</given-names></name>, <name><surname>Opel</surname><given-names>RA</given-names></name>, <name><surname>Weymann</surname><given-names>KB</given-names></name>, <name><surname>Chau</surname><given-names>AQ</given-names></name>, <name><surname>Papesh</surname><given-names>MA</given-names></name>, <name><surname>Callahan</surname><given-names>ML</given-names></name>, <etal>et al</etal>. <article-title>Sleep Disturbances in Traumatic Brain Injury: Associations With Sensory Sensitivity</article-title>. <source>J Clin Sleep Med</source>. <year>2018</year>;<volume>14</volume>: <fpage>1177</fpage>–<lpage>1186</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5664/jcsm.7220</pub-id>
<?supplied-pmid 29991430?><pub-id pub-id-type="pmid">29991430</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Elliott</surname><given-names>JE</given-names></name>, <name><surname>Opel</surname><given-names>RA</given-names></name>, <name><surname>Pleshakov</surname><given-names>D</given-names></name>, <name><surname>Rachakonda</surname><given-names>T</given-names></name>, <name><surname>Chau</surname><given-names>AQ</given-names></name>, <name><surname>Weymann</surname><given-names>KB</given-names></name>, <etal>et al</etal>. <article-title>Posttraumatic stress disorder increases the odds of REM sleep behavior disorder and other parasomnias in Veterans with and without comorbid traumatic brain injury</article-title>. <source>Sleep</source>. <year>2020</year>;<volume>43</volume>: <fpage>zsz237</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/sleep/zsz237</pub-id><?supplied-pmid 31587047?><pub-id pub-id-type="pmid">31587047</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Sandsmark</surname><given-names>DK</given-names></name>, <name><surname>Elliott</surname><given-names>JE</given-names></name>, <name><surname>Lim</surname><given-names>MM</given-names></name>. <article-title>Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies</article-title>. <source>Sleep</source>. <year>2017</year>;<volume>40</volume>: <fpage>zsx044</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/sleep/zsx044</pub-id><?supplied-pmid 28329120?><pub-id pub-id-type="pmid">28329120</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Cantu</surname><given-names>D</given-names></name>, <name><surname>Walker</surname><given-names>K</given-names></name>, <name><surname>Andresen</surname><given-names>L</given-names></name>, <name><surname>Taylor-Weiner</surname><given-names>A</given-names></name>, <name><surname>Hampton</surname><given-names>D</given-names></name>, <name><surname>Tesco</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Traumatic Brain Injury Increases Cortical Glutamate Network Activity by Compromising GABAergic Control</article-title>. <source>Cereb Cortex</source>. <year>2015</year>;<volume>25</volume>: <fpage>2306</fpage>–<lpage>2320</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/cercor/bhu041</pub-id>
<?supplied-pmid 24610117?><pub-id pub-id-type="pmid">24610117</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Elliott</surname><given-names>JE</given-names></name>, <name><surname>De Luche</surname><given-names>SE</given-names></name>, <name><surname>Churchill</surname><given-names>MJ</given-names></name>, <name><surname>Moore</surname><given-names>C</given-names></name>, <name><surname>Cohen</surname><given-names>AS</given-names></name>, <name><surname>Meshul</surname><given-names>CK</given-names></name>, <etal>et al</etal>. <article-title>Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice</article-title>. <source>Sleep</source>. <year>2018</year>;<volume>41</volume>: <fpage>zsx212</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/sleep/zsx212</pub-id><?supplied-pmid 29315422?><pub-id pub-id-type="pmid">29315422</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Baumann</surname><given-names>CR</given-names></name>, <name><surname>Bassetti</surname><given-names>CL</given-names></name>, <name><surname>Valko</surname><given-names>PO</given-names></name>, <name><surname>Haybaeck</surname><given-names>J</given-names></name>, <name><surname>Keller</surname><given-names>M</given-names></name>, <name><surname>Clark</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Loss of hypocretin (orexin) neurons with traumatic brain injury</article-title>. <source>Ann Neurol</source>. <year>2009</year>;<volume>66</volume>: <fpage>555</fpage>–<lpage>559</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/ana.21836</pub-id>
<?supplied-pmid 19847903?><pub-id pub-id-type="pmid">19847903</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Shekleton</surname><given-names>JA</given-names></name>, <name><surname>Parcell</surname><given-names>DL</given-names></name>, <name><surname>Redman</surname><given-names>JR</given-names></name>, <name><surname>Phipps-Nelson</surname><given-names>J</given-names></name>, <name><surname>Ponsford</surname><given-names>JL</given-names></name>, <name><surname>Rajaratnam</surname><given-names>SMW</given-names></name>. <article-title>Sleep disturbance and melatonin levels following traumatic brain injury</article-title>. <source>Neurology</source>. <year>2010</year>;<volume>74</volume>: <fpage>1732</fpage>–<lpage>1738</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1212/WNL.0b013e3181e0438b</pub-id>
<?supplied-pmid 20498441?><pub-id pub-id-type="pmid">20498441</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Dinges</surname><given-names>DF</given-names></name>. <article-title>Sleep in space flight breath easy—Sleep less?</article-title><source>Am J Respir Crit Care Med</source>. <year>2001</year>;<volume>164</volume>: <fpage>337</fpage>–<lpage>338</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1164/ajrccm.164.3.2105072a</pub-id>
<?supplied-pmid 11500328?><pub-id pub-id-type="pmid">11500328</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Banks</surname><given-names>S</given-names></name>, <name><surname>Dinges</surname><given-names>DF</given-names></name>. <article-title>Behavioral and physiological consequences of sleep restriction</article-title>. <source>J Clin Sleep Med</source>. <year>2007</year>;<volume>3</volume>: <fpage>519</fpage>–<lpage>528</lpage>. <?supplied-pmid 17803017?><pub-id pub-id-type="pmid">17803017</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Dinges</surname><given-names>DF</given-names></name>, <name><surname>Douglas</surname><given-names>SD</given-names></name>, <name><surname>Hamarman</surname><given-names>S</given-names></name>, <name><surname>Zaugg</surname><given-names>L</given-names></name>, <name><surname>Kapoor</surname><given-names>S</given-names></name>. <article-title>Sleep deprivation and human immune function</article-title>. <source>Adv Neuroimmunol</source>. <year>1995</year>;<volume>5</volume>: <fpage>97</fpage>–<lpage>110</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0960-5428(95)00002-j</pub-id>
<?supplied-pmid 7496616?><pub-id pub-id-type="pmid">7496616</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Durmer</surname><given-names>JS</given-names></name>, <name><surname>Dinges</surname><given-names>DF</given-names></name>. <article-title>Neurocognitive Consequences of Sleep Deprivation</article-title>. <source>Semin Neurol</source>. <year>2005</year>;<volume>25</volume>: <fpage>117</fpage>–<lpage>129</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1055/s-2005-867080</pub-id>
<?supplied-pmid 15798944?><pub-id pub-id-type="pmid">15798944</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Turk</surname><given-names>DC</given-names></name>, <name><surname>Dworkin</surname><given-names>RH</given-names></name>, <name><surname>Revicki</surname><given-names>D</given-names></name>, <name><surname>Harding</surname><given-names>G</given-names></name>, <name><surname>Burke</surname><given-names>LB</given-names></name>, <name><surname>Cella</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain</article-title>. <source>Pain</source>. <year>2008</year>;<volume>137</volume>: <fpage>276</fpage>–<lpage>285</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.pain.2007.09.002</pub-id>
<?supplied-pmid 17937976?><pub-id pub-id-type="pmid">17937976</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Cappuccio</surname><given-names>FP</given-names></name>, <name><surname>D’Elia</surname><given-names>L</given-names></name>, <name><surname>Strazzullo</surname><given-names>P</given-names></name>, <name><surname>Miller</surname><given-names>MA</given-names></name>. <article-title>Sleep duration and all-cause mortality: A systematic review and meta-analysis of prospective studies</article-title>. <source>Sleep</source>. <year>2010</year>;<volume>33</volume>: <fpage>585</fpage>–<lpage>592</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/sleep/33.5.585</pub-id>
<?supplied-pmid 20469800?><pub-id pub-id-type="pmid">20469800</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Watson</surname><given-names>NF</given-names></name>, <name><surname>Badr</surname><given-names>MS</given-names></name>, <name><surname>Belenky</surname><given-names>G</given-names></name>, <name><surname>Bliwise</surname><given-names>DL</given-names></name>, <name><surname>Buxton</surname><given-names>OM</given-names></name>, <name><surname>Buysse</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the Recommended Amount of Sleep for a Healthy Adult: Methodology and Discussion</article-title>. <source>Sleep</source>. <year>2015</year>;<volume>38</volume>: <fpage>1161</fpage>–<lpage>1183</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5665/sleep.4886</pub-id>
<?supplied-pmid 26194576?><pub-id pub-id-type="pmid">26194576</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Rao</surname><given-names>V</given-names></name>, <name><surname>Spiro</surname><given-names>J</given-names></name>, <name><surname>Vaishnavi</surname><given-names>S</given-names></name>, <name><surname>Rastogi</surname><given-names>P</given-names></name>, <name><surname>Mielke</surname><given-names>M</given-names></name>, <name><surname>Noll</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Prevalence and types of sleep disturbances acutely after traumatic brain injury</article-title>. <source>Brain Inj</source>. <year>2008</year>;<volume>22</volume>: <fpage>381</fpage>–<lpage>386</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/02699050801935260</pub-id>
<?supplied-pmid 18415718?><pub-id pub-id-type="pmid">18415718</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Makley</surname><given-names>MJ</given-names></name>, <name><surname>Gerber</surname><given-names>D</given-names></name>, <name><surname>Newman</surname><given-names>JK</given-names></name>, <name><surname>Philippus</surname><given-names>A</given-names></name>, <name><surname>Monden</surname><given-names>KR</given-names></name>, <name><surname>Biggs</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Optimized Sleep After Brain Injury (OSABI): A Pilot Study of a Sleep Hygiene Intervention for Individuals With Moderate to Severe Traumatic Brain Injury</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2020</year>;<volume>34</volume>: <fpage>111</fpage>–<lpage>121</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1545968319895478</pub-id>
<?supplied-pmid 31884895?><pub-id pub-id-type="pmid">31884895</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Makley</surname><given-names>MJ</given-names></name>, <name><surname>Johnson-Greene</surname><given-names>L</given-names></name>, <name><surname>Tarwater</surname><given-names>PM</given-names></name>, <name><surname>Kreuz</surname><given-names>AJ</given-names></name>, <name><surname>Spiro</surname><given-names>J</given-names></name>, <name><surname>Rao</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Return of Memory and Sleep Efficiency Following Moderate to Severe Closed Head Injury</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2008</year>;<volume>23</volume>: <fpage>320</fpage>–<lpage>326</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Zollman</surname><given-names>FS</given-names></name>, <name><surname>Larson</surname><given-names>EB</given-names></name>, <name><surname>Wasek-Throm</surname><given-names>LK</given-names></name>, <name><surname>Cyborski</surname><given-names>CM</given-names></name>, <name><surname>Bode</surname><given-names>RK</given-names></name>. <article-title>Acupuncture for Treatment of Insomnia in Patients With Traumatic Brain Injury: A Pilot Intervention Study</article-title>. <source>J Head Trauma Rehabil</source>. <year>2012</year>;<volume>27</volume>: <fpage>135</fpage>–<lpage>142</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/HTR.0b013e3182051397</pub-id>
<?supplied-pmid 21386714?><pub-id pub-id-type="pmid">21386714</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Viola-Saltzman</surname><given-names>M</given-names></name>, <name><surname>Musleh</surname><given-names>C</given-names></name>. <article-title>Traumatic brain injury-induced sleep disorders</article-title>. <source>Neuropsychiatr Dis Treat</source>. <year>2016</year>;<volume>12</volume>: <fpage>339</fpage>–<lpage>348</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2147/NDT.S69105</pub-id>
<?supplied-pmid 26929626?><pub-id pub-id-type="pmid">26929626</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Viola-Saltzman</surname><given-names>M</given-names></name>, <name><surname>Watson</surname><given-names>NF</given-names></name>. <article-title>Traumatic Brain Injury and Sleep Disorders</article-title>. <source>Neurol Clin</source>. <year>2012</year>;<volume>30</volume>: <fpage>1299</fpage>–<lpage>1312</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ncl.2012.08.008</pub-id>
<?supplied-pmid 23099139?><pub-id pub-id-type="pmid">23099139</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Ayalon</surname><given-names>L</given-names></name>, <name><surname>Borodkin</surname><given-names>K</given-names></name>, <name><surname>Dishon</surname><given-names>L</given-names></name>, <name><surname>Kanety</surname><given-names>H</given-names></name>, <name><surname>Dagan</surname><given-names>Y</given-names></name>. <article-title>Circadian rhythm sleep disorders following mild traumatic brain injury</article-title>. <source>Neurology</source>. <year>2007</year>;<volume>68</volume>: <fpage>1136</fpage>–<lpage>1140</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1212/01.wnl.0000258672.52836.30</pub-id>
<?supplied-pmid 17404196?><pub-id pub-id-type="pmid">17404196</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Grima</surname><given-names>NA</given-names></name>, <name><surname>Ponsford</surname><given-names>JL</given-names></name>, <name><surname>St Hilaire</surname><given-names>MA</given-names></name>, <name><surname>Mansfield</surname><given-names>D</given-names></name>, <name><surname>Rajaratnam</surname><given-names>SMW</given-names></name>. <article-title>Circadian Melatonin Rhythm Following Traumatic Brain Injury</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2016</year>;<volume>30</volume>: <fpage>972</fpage>–<lpage>977</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1545968316650279</pub-id>
<?supplied-pmid 27221043?><pub-id pub-id-type="pmid">27221043</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>LeGates</surname><given-names>TA</given-names></name>, <name><surname>Altimus</surname><given-names>CM</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Lee</surname><given-names>H-K</given-names></name>, <name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Zhao</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Aberrant light directly impairs mood and learning through melanopsin-expressing neurons</article-title>. <source>Nature</source>. <year>2012</year>;<volume>491</volume>: <fpage>594</fpage>–<lpage>598</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nature11673</pub-id>
<?supplied-pmid 23151476?><pub-id pub-id-type="pmid">23151476</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Lam</surname><given-names>RW</given-names></name>, <name><surname>Levitt</surname><given-names>AJ</given-names></name>, <name><surname>Levitan</surname><given-names>RD</given-names></name>, <name><surname>Michalak</surname><given-names>EE</given-names></name>, <name><surname>Cheung</surname><given-names>AH</given-names></name>, <name><surname>Morehouse</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder a randomized clinical trial</article-title>. <source>JAMA Psychiatry</source>. <year>2016</year>;<volume>73</volume>: <fpage>56</fpage>–<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.2235</pub-id>
<?supplied-pmid 26580307?><pub-id pub-id-type="pmid">26580307</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>LeGates</surname><given-names>TA</given-names></name>, <name><surname>Fernandez</surname><given-names>DC</given-names></name>, <name><surname>Hattar</surname><given-names>S</given-names></name>. <article-title>Light as a central modulator of circadian rhythms, sleep and affect</article-title>. <source>Nat Rev Neurosci</source>. <year>2014</year>;<volume>15</volume>: <fpage>443</fpage>–<lpage>54</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/nrn3743</pub-id>
<?supplied-pmid 24917305?><pub-id pub-id-type="pmid">24917305</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Raikes</surname><given-names>AC</given-names></name>, <name><surname>Killgore</surname><given-names>WDS</given-names></name>. <article-title>Potential for the development of light therapies in mild traumatic brain injury</article-title>. <source>Concussion</source>. <year>2018</year>;<volume>3</volume>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2217/cnc-2018-0006</pub-id><?supplied-pmid 30370058?><pub-id pub-id-type="pmid">30370058</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Terman</surname><given-names>M</given-names></name>, <name><surname>Terman</surname><given-names>JS</given-names></name>. <article-title>Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects</article-title>. <source>CNS Spectr</source>. <year>2005</year>;<volume>10</volume>: <fpage>647</fpage>–<lpage>63</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/s1092852900019611</pub-id>
<?supplied-pmid 16041296?><pub-id pub-id-type="pmid">16041296</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Riemersma-van der Lek</surname><given-names>RF</given-names></name>, <name><surname>Swaab</surname><given-names>DF</given-names></name>, <name><surname>Twisk</surname><given-names>J</given-names></name>, <name><surname>Hol</surname><given-names>EM</given-names></name>, <name><surname>Hoogendijk</surname><given-names>WJ</given-names></name>, <name><surname>van Someren</surname><given-names>EJW</given-names></name>. <article-title>Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities</article-title>. <source>JAMA</source>. <year>2008</year>;<volume>299</volume>: <fpage>2642</fpage>–<lpage>2655</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jama.299.22.2642</pub-id>
<?supplied-pmid 18544724?><pub-id pub-id-type="pmid">18544724</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Lockley</surname><given-names>SW</given-names></name>, <name><surname>Evans</surname><given-names>EE</given-names></name>, <name><surname>Scheer</surname><given-names>FAJL</given-names></name>, <name><surname>Brainard</surname><given-names>GC</given-names></name>, <name><surname>Czeisler</surname><given-names>CA</given-names></name>, <name><surname>Aeschbach</surname><given-names>D</given-names></name>. <article-title>Short-wavelength sensitivity for the direct effects of light on alertness, vigilance, and the waking electroencephalogram in humans</article-title>. <source>Sleep</source>. <year>2006</year>;<volume>29</volume>: <fpage>161</fpage>–<lpage>168</lpage>. <?supplied-pmid 16494083?><pub-id pub-id-type="pmid">16494083</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Ancoli-israel</surname><given-names>S</given-names></name>, <name><surname>Gehrman</surname><given-names>P</given-names></name>, <name><surname>Martin</surname><given-names>JL</given-names></name>, <name><surname>Shochat</surname><given-names>T</given-names></name>, <name><surname>Marler</surname><given-names>M</given-names></name>, <name><surname>Corey-bloom</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer’s Disease Patients Increased Light Exposure Consolidates Sleep and Strengthens Circadian Rhythms in Severe Alzheimer’s Disease Patients</article-title>. <source>Behav Sleep Med</source>. <year>2003</year>;<volume>1</volume>: <fpage>22</fpage>–<lpage>36</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1207/S15402010BSM0101_4</pub-id>
<?supplied-pmid 15600135?><pub-id pub-id-type="pmid">15600135</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Chellappa</surname><given-names>S</given-names></name>, <name><surname>Gordijn</surname><given-names>MCM</given-names></name>, <name><surname>Cajochen</surname><given-names>C</given-names></name>. <article-title>Can light make us bright? Effects of light on cognition sleep</article-title>. <source>Prog Brain Res</source>. <year>2011</year>;<volume>190</volume>: <fpage>119</fpage>–<lpage>133</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/B978-0-444-53817-8.00007-4</pub-id>
<?supplied-pmid 21531248?><pub-id pub-id-type="pmid">21531248</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Killgore</surname><given-names>WDS</given-names></name>, <name><surname>Vanuk</surname><given-names>JR</given-names></name>, <name><surname>Shane</surname><given-names>BR</given-names></name>, <name><surname>Weber</surname><given-names>M</given-names></name>, <name><surname>Bajaj</surname><given-names>S</given-names></name>. <article-title>A randomized, double-blind, placebo-controlled trial of blue wavelength light exposure on sleep and recovery of brain structure, function, and cognition following mild traumatic brain injury</article-title>. <source>Neurobiol Dis</source>. <year>2020</year>;<volume>134</volume>: <fpage>104679</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.nbd.2019.104679</pub-id><?supplied-pmid 31751607?><pub-id pub-id-type="pmid">31751607</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Raikes</surname><given-names>AC</given-names></name>, <name><surname>Dailey</surname><given-names>NS</given-names></name>, <name><surname>Shane</surname><given-names>BR</given-names></name>, <name><surname>Forbeck</surname><given-names>B</given-names></name>, <name><surname>Alkozei</surname><given-names>A</given-names></name>, <name><surname>Killgore</surname><given-names>WDS</given-names></name>. <article-title>Daily Morning Blue Light Therapy Improves Daytime Sleepiness, Sleep Quality, and Quality of Life Following a Mild Traumatic Brain Injury</article-title>. <source>J Head Trauma Rehabil</source>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Sinclair</surname><given-names>KL</given-names></name>, <name><surname>Ponsford</surname><given-names>JL</given-names></name>, <name><surname>Taffe</surname><given-names>J</given-names></name>, <name><surname>Lockley</surname><given-names>SW</given-names></name>, <name><surname>Rajaratnam</surname><given-names>SMW</given-names></name>. <article-title>Randomized Controlled Trial of Light Therapy for Fatigue Following Traumatic Brain Injury</article-title>. <source>Neurorehabil Neural Repair</source>. <year>2013</year>;<volume>28</volume>: <fpage>303</fpage>–<lpage>313</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1545968313508472</pub-id>
<?supplied-pmid 24213962?><pub-id pub-id-type="pmid">24213962</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Quera Salva</surname><given-names>M-A</given-names></name>, <name><surname>Azabou</surname><given-names>E</given-names></name>, <name><surname>Hartley</surname><given-names>S</given-names></name>, <name><surname>Sauvagnac</surname><given-names>R</given-names></name>, <name><surname>Leotard</surname><given-names>A</given-names></name>, <name><surname>Vaugier</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Blue-Enriched White Light Therapy Reduces Fatigue in Survivors of Severe Traumatic Brain Injury: A Randomized Controlled Trial</article-title>. <source>J Head Trauma Rehabil</source>. <year>2020</year>;<volume>35</volume>: <fpage>E78</fpage>–<lpage>E85</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/HTR.0000000000000500</pub-id>
<?supplied-pmid 31246878?><pub-id pub-id-type="pmid">31246878</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Youngstedt</surname><given-names>SD</given-names></name>, <name><surname>Kline</surname><given-names>CE</given-names></name>, <name><surname>Reynolds</surname><given-names>AM</given-names></name>, <name><surname>Crowley</surname><given-names>SK</given-names></name>, <name><surname>Burch</surname><given-names>JB</given-names></name>, <name><surname>Khan</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Bright Light Treatment of Combat-related PTSD: A Randomized Controlled Trial</article-title>. <source>Mil Med</source>. <year>2021</year>;<volume>00</volume>: <fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>McInnes</surname><given-names>K</given-names></name>, <name><surname>Friesen</surname><given-names>CL</given-names></name>, <name><surname>MacKenzie</surname><given-names>DE</given-names></name>, <name><surname>Westwood</surname><given-names>DA</given-names></name>, <name><surname>Boe</surname><given-names>SG</given-names></name>. <article-title>Mild Traumatic Brain Injury (mTBI) and chronic cognitive impairment: A scoping review</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Chesson</surname><given-names>AL</given-names></name>, <name><surname>Littner</surname><given-names>M</given-names></name>, <name><surname>Davila</surname><given-names>D</given-names></name>, <name><surname>Anderson</surname><given-names>WM</given-names></name>, <name><surname>Grigg-damberger</surname><given-names>M</given-names></name>, <name><surname>Hartse</surname><given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Practice Parameters for the Use of Light Therapy in the Treatment of Sleep Disorders</article-title>. <source>Sleep</source>. <year>1999</year>;<volume>22</volume>: <fpage>641</fpage>–<lpage>660</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/sleep/22.5.641</pub-id>
<?supplied-pmid 10450599?><pub-id pub-id-type="pmid">10450599</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Penders</surname><given-names>TM</given-names></name>, <name><surname>Stanciu</surname><given-names>CN</given-names></name>, <name><surname>Schoemann</surname><given-names>AM</given-names></name>, <name><surname>Ninan</surname><given-names>PT</given-names></name>, <name><surname>Bloch</surname><given-names>R</given-names></name>, <name><surname>Saeed</surname><given-names>SA</given-names></name>. <article-title>Bright Light Therapy as Augmentation of Pharmacotherapy for Treatment of Depression</article-title>. <source>Prim Care Companion CNS Disord</source>. <year>2016</year>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4088/PCC.15r01906</pub-id><?supplied-pmid 27835725?><pub-id pub-id-type="pmid">27835725</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Anderson</surname><given-names>JL</given-names></name>, <name><surname>Glod</surname><given-names>CA</given-names></name>, <name><surname>Dai</surname><given-names>J</given-names></name>, <name><surname>Cao</surname><given-names>Y</given-names></name>, <name><surname>Lockley</surname><given-names>SW</given-names></name>. <article-title>Lux vs. wavelength in light treatment of seasonal affective disorder</article-title>. <source>Acta Psychiatr Scand</source>. <year>2009</year>;<volume>120</volume>: <fpage>203</fpage>–<lpage>212</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/j.1600-0447.2009.01345.x</pub-id>
<?supplied-pmid 19207131?><pub-id pub-id-type="pmid">19207131</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Cifu</surname><given-names>D</given-names></name>, <name><surname>Hurley</surname><given-names>R</given-names></name>, <name><surname>Peterson</surname><given-names>M</given-names></name>, <name><surname>Cornis-Pop</surname><given-names>M</given-names></name>, <name><surname>Rikli</surname><given-names>PA</given-names></name>, <name><surname>Ruff</surname><given-names>RL</given-names></name>, <etal>et al</etal>. <article-title>VA/DoD Clinical practice guideline: Management of Concussion/Mild Traumatic Brain Injury</article-title>. <source>J Rehabil Res Dev</source>. <year>2009</year>;<volume>46</volume>: <fpage>CP1</fpage>–<lpage>68</lpage>. <?supplied-pmid 20108447?><pub-id pub-id-type="pmid">20108447</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Thabane</surname><given-names>L</given-names></name>, <name><surname>Hopewell</surname><given-names>S</given-names></name>, <name><surname>Lancaster</surname><given-names>GA</given-names></name>, <name><surname>Bond</surname><given-names>CM</given-names></name>, <name><surname>Coleman</surname><given-names>CL</given-names></name>, <name><surname>Campbell</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. <article-title>Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials</article-title>. <source>Pilot feasibility Stud</source>. <year>2016</year>;<volume>2</volume>: <fpage>25</fpage>. Available: <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27965844" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/pubmed/27965844</ext-link>.<pub-id pub-id-type="pmid">27965844</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Eldridge</surname><given-names>SM</given-names></name>, <name><surname>Chan</surname><given-names>CL</given-names></name>, <name><surname>Campbell</surname><given-names>MJ</given-names></name>, <name><surname>Bond</surname><given-names>CM</given-names></name>, <name><surname>Hopewell</surname><given-names>S</given-names></name>, <name><surname>Thabane</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>CONSORT 2010 statement: extension to randomised pilot and feasibility trials</article-title>. <source>BMJ</source>. <year>2016</year>;<volume>355</volume>: <fpage>i5239</fpage>. Available: <ext-link xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/27777223" ext-link-type="uri">http://www.ncbi.nlm.nih.gov/pubmed/27777223</ext-link>.<pub-id pub-id-type="pmid">27777223</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Eldridge</surname><given-names>SM</given-names></name>, <name><surname>Lancaster</surname><given-names>GA</given-names></name>, <name><surname>Campbell</surname><given-names>MJ</given-names></name>, <name><surname>Thabane</surname><given-names>L</given-names></name>, <name><surname>Hopewell</surname><given-names>S</given-names></name>, <name><surname>Coleman</surname><given-names>CL</given-names></name>, <etal>et al</etal>. <article-title>Defining feasibility and pilot studies in preparation for randomised controlled trials: Development of a conceptual framework</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>: <fpage>1</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0150205</pub-id>
<?supplied-pmid 26978655?><pub-id pub-id-type="pmid">26978655</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Spitschan</surname><given-names>M</given-names></name>, <name><surname>Stefani</surname><given-names>O</given-names></name>, <name><surname>Blattner</surname><given-names>P</given-names></name>, <name><surname>Gronfier</surname><given-names>C</given-names></name>, <name><surname>Lockley</surname><given-names>S</given-names></name>, <name><surname>Lucas</surname><given-names>R</given-names></name>. <article-title>How to Report Light Exposure in Human Chronobiology and Sleep Research Experiments</article-title>. <source>Clocks &amp; Sleep</source>. <year>2019</year>;<volume>1</volume>: <fpage>280</fpage>–<lpage>289</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/clockssleep1030024</pub-id>
<?supplied-pmid 31281903?><pub-id pub-id-type="pmid">31281903</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref052">
                <label>52</label>
                <mixed-citation publication-type="journal"><name><surname>Jean-Louis</surname><given-names>G</given-names></name>, <name><surname>Kripke</surname><given-names>DF</given-names></name>, <name><surname>Mason</surname><given-names>WJ</given-names></name>, <name><surname>Elliott</surname><given-names>JA</given-names></name>, <name><surname>Youngstedt</surname><given-names>SD</given-names></name>. <article-title>Sleep estimation from wrist movement quantified by different actigraphic modalities</article-title>. <source>J Neurosci Methods</source>. <year>2001</year>;<volume>105</volume>: <fpage>185</fpage>–<lpage>191</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0165-0270(00)00364-2</pub-id>
<?supplied-pmid 11275275?><pub-id pub-id-type="pmid">11275275</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref053">
                <label>53</label>
                <mixed-citation publication-type="book"><name><surname>Morin</surname><given-names>CM</given-names></name>. <part-title>Insomnia</part-title>. <source>Psychological assessment and management</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Guilford Press</publisher-name>; <year>1993</year>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref054">
                <label>54</label>
                <mixed-citation publication-type="journal"><name><surname>Bastien</surname><given-names>CH</given-names></name>, <name><surname>Vallières</surname><given-names>A</given-names></name>, <name><surname>Morin</surname><given-names>CM</given-names></name>. <article-title>Validation of the insomnia severity index as an outcome measure for insomnia research</article-title>. <source>Sleep Med</source>. <year>2001</year>;<volume>2</volume>: <fpage>297</fpage>–<lpage>307</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s1389-9457(00)00065-4</pub-id>
<?supplied-pmid 11438246?><pub-id pub-id-type="pmid">11438246</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref055">
                <label>55</label>
                <mixed-citation publication-type="journal"><name><surname>Mastin</surname><given-names>DF</given-names></name>, <name><surname>Bryson</surname><given-names>J</given-names></name>, <name><surname>Corwyn</surname><given-names>R</given-names></name>. <article-title>Assessment of sleep hygiene using the sleep hygiene index</article-title>. <source>J Behav Med</source>. <year>2006</year>;<volume>29</volume>: <fpage>223</fpage>–<lpage>227</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10865-006-9047-6</pub-id>
<?supplied-pmid 16557353?><pub-id pub-id-type="pmid">16557353</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Belanger</surname><given-names>HG</given-names></name>, <name><surname>Kretzmer</surname><given-names>T</given-names></name>, <name><surname>Vanderploeg</surname><given-names>RD</given-names></name>, <name><surname>French</surname><given-names>LM</given-names></name>. <article-title>Symptom complaints following combat-related traumatic brain injury: Relationship to traumatic brain injury severity and posttraumatic stress disorder</article-title>. <source>J Int Neuropsychol Soc</source>. <year>2009</year>;<volume>16</volume>: <fpage>194</fpage>–<lpage>199</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1017/S1355617709990841</pub-id>
<?supplied-pmid 19758488?><pub-id pub-id-type="pmid">19758488</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref057">
                <label>57</label>
                <mixed-citation publication-type="journal"><name><surname>Bulson</surname><given-names>R</given-names></name>, <name><surname>Jun</surname><given-names>W</given-names></name>, <name><surname>Hayes</surname><given-names>J</given-names></name>. <article-title>Visual symptomatology and referral patterns for Operation Iraqi Freedom and Operation Enduring Freedom veterans with traumatic brain injury</article-title>. <source>J Rehabil Res Dev</source>. <year>2012</year>;<volume>49</volume>: <fpage>1075</fpage>–<lpage>1082</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1682/jrrd.2011.02.0017</pub-id>
<?supplied-pmid 23341280?><pub-id pub-id-type="pmid">23341280</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref058">
                <label>58</label>
                <mixed-citation publication-type="journal"><name><surname>Vanderploeg</surname><given-names>RD</given-names></name>, <name><surname>Cooper</surname><given-names>DB</given-names></name>, <name><surname>Belanger</surname><given-names>HG</given-names></name>, <name><surname>Donnell</surname><given-names>AJ</given-names></name>, <name><surname>Kennedy</surname><given-names>JE</given-names></name>, <name><surname>Hopewell</surname><given-names>CA</given-names></name>, <etal>et al</etal>. <article-title>Screening for Postdeployment Conditions: Development and Cross-Validation of an Embedded Validity Scale in the Neurobehavioral Symptom Inventory</article-title>. <source>J Head Trauma Rehabil</source>. <year>2014</year>;<volume>29</volume>: <fpage>1</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/HTR.0b013e318281966e</pub-id>
<?supplied-pmid 23474880?><pub-id pub-id-type="pmid">23474880</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Blevins</surname><given-names>CA</given-names></name>, <name><surname>Weather</surname><given-names>FW</given-names></name>, <name><surname>Davis</surname><given-names>MT</given-names></name>, <name><surname>Witte</surname><given-names>TK</given-names></name>, <name><surname>Domino</surname><given-names>JL</given-names></name>. <article-title>The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation</article-title>. <source>J Trauma Stress</source>. <year>2015</year>;<volume>28</volume>: <fpage>489</fpage>–<lpage>498</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jts.22059</pub-id>
<?supplied-pmid 26606250?><pub-id pub-id-type="pmid">26606250</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref060">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Edwards</surname><given-names>KA</given-names></name>, <name><surname>Gill</surname><given-names>JM</given-names></name>, <name><surname>Pattinson</surname><given-names>CL</given-names></name>, <name><surname>Lai</surname><given-names>C</given-names></name>, <name><surname>Brière</surname><given-names>M</given-names></name>, <name><surname>Rogers</surname><given-names>NJ</given-names></name>, <etal>et al</etal>. <article-title>Interleukin-6 is associated with acute concussion in military combat personnel</article-title>. <source>BMC Neurol</source>. <year>2020</year>;<volume>20</volume>: <fpage>209</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12883-020-01760-x</pub-id><?supplied-pmid 32450801?><pub-id pub-id-type="pmid">32450801</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Guedes</surname><given-names>VA</given-names></name>, <name><surname>Kenney</surname><given-names>K</given-names></name>, <name><surname>Shahim</surname><given-names>P</given-names></name>, <name><surname>Qu</surname><given-names>B</given-names></name>, <name><surname>Lai</surname><given-names>C</given-names></name>, <name><surname>Devoto</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Exosomal neurofilament light A prognostic biomarker for remote symptoms after mild traumatic brain injury?</article-title><source>Neurology</source>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref062">
                <label>62</label>
                <mixed-citation publication-type="journal"><name><surname>Mondello</surname><given-names>S</given-names></name>, <name><surname>Buki</surname><given-names>A</given-names></name>, <name><surname>Barzo</surname><given-names>P</given-names></name>, <name><surname>Randall</surname><given-names>J</given-names></name>, <name><surname>Provuncher</surname><given-names>G</given-names></name>, <name><surname>Hanlon</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>CSF and Plasma Amyloid-β Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury</article-title>. <source>Sci Rep</source>. <year>2014</year>;<volume>3</volume>: <fpage>2</fpage>–<lpage>7</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/srep06446</pub-id>
<?supplied-pmid 25300247?><pub-id pub-id-type="pmid">25300247</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Korley</surname><given-names>FK</given-names></name>, <name><surname>Yue</surname><given-names>JK</given-names></name>, <name><surname>Wilson</surname><given-names>DH</given-names></name>, <name><surname>Hrusovsky</surname><given-names>K</given-names></name>, <name><surname>Diaz-Arrastia</surname><given-names>R</given-names></name>, <name><surname>Ferguson</surname><given-names>AR</given-names></name>, <etal>et al</etal>. <article-title>Performance Evaluation of a Multiplex Assay for Simultaneous Detection of Four Clinically Relevant Traumatic Brain Injury Biomarkers</article-title>. <source>J Neurotrauma</source>. <year>2019</year>;<volume>36</volume>: <fpage>182</fpage>–<lpage>187</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref064">
                <label>64</label>
                <mixed-citation publication-type="journal"><name><surname>van Maanen</surname><given-names>A</given-names></name>, <name><surname>Meijer</surname><given-names>AM</given-names></name>, <name><surname>van der Heijden</surname><given-names>KB</given-names></name>, <name><surname>Oort</surname><given-names>FJ</given-names></name>. <article-title>The effects of light therapy on sleep problems: A systematic review and meta-analysis</article-title>. <source>Sleep Med Rev</source>. <year>2016</year>;<volume>29</volume>: <fpage>52</fpage>–<lpage>62</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.smrv.2015.08.009</pub-id>
<?supplied-pmid 26606319?><pub-id pub-id-type="pmid">26606319</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref065">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Lewy</surname><given-names>AJ</given-names></name>, <name><surname>Wehr</surname><given-names>TA</given-names></name>, <name><surname>Goodwin</surname><given-names>FK</given-names></name>, <name><surname>Newsome</surname><given-names>DA</given-names></name>, <name><surname>Markey</surname><given-names>SP</given-names></name>. <article-title>Light Suppresses Melatonin Secretion in Humans</article-title>. <source>Science</source>. <year>1980</year>;<volume>210</volume>: <fpage>1267</fpage>–<lpage>1269</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.7434030</pub-id>
<?supplied-pmid 7434030?><pub-id pub-id-type="pmid">7434030</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref066">
                <label>66</label>
                <mixed-citation publication-type="journal"><name><surname>Czeisler</surname><given-names>CA</given-names></name>, <name><surname>Shanahan</surname><given-names>TL</given-names></name>, <name><surname>Klerman</surname><given-names>EB</given-names></name>, <name><surname>Martens</surname><given-names>H</given-names></name>, <name><surname>Brotman</surname><given-names>DJ</given-names></name>, <name><surname>Emens</surname><given-names>JS</given-names></name>, <etal>et al</etal>. <article-title>Suppression of Melatonin Secretion in Some Blind Patients by Exposure to Bright Light</article-title>. <source>N Engl J Med</source>. <year>1995</year>;<volume>332</volume>: <fpage>6</fpage>–<lpage>11</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJM199501053320102</pub-id>
<?supplied-pmid 7990870?><pub-id pub-id-type="pmid">7990870</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref067">
                <label>67</label>
                <mixed-citation publication-type="journal"><name><surname>Kripke</surname><given-names>DF</given-names></name>, <name><surname>Elliott</surname><given-names>JA</given-names></name>, <name><surname>Youngstedt</surname><given-names>SD</given-names></name>, <name><surname>Rex</surname><given-names>KM</given-names></name>. <article-title>Circadian phase response curves to light in older and young women and men</article-title>. <source>J Circadian Rhythms</source>. <year>2007</year>;<volume>5</volume>: <fpage>1</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">17210086</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref068">
                <label>68</label>
                <mixed-citation publication-type="journal"><name><surname>Hattar</surname><given-names>S</given-names></name>, <name><surname>Liao</surname><given-names>HW</given-names></name>, <name><surname>Takao</surname><given-names>M</given-names></name>, <name><surname>Berson</surname><given-names>DM</given-names></name>, <name><surname>Yau</surname><given-names>KW</given-names></name>. <article-title>Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity</article-title>. <source>Science</source>. <year>2002</year>;<volume>295</volume>: <fpage>1065</fpage>–<lpage>1070</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1126/science.1069609</pub-id>
<?supplied-pmid 11834834?><pub-id pub-id-type="pmid">11834834</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref069">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>TM</given-names></name>, <name><surname>Chen</surname><given-names>SK</given-names></name>, <name><surname>Hattar</surname><given-names>S</given-names></name>. <article-title>Intrinsically photosensitive retinal ganglion cells: Many subtypes, diverse functions</article-title>. <source>Trends Neurosci</source>. <year>2011</year>;<volume>34</volume>: <fpage>572</fpage>–<lpage>580</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.tins.2011.07.001</pub-id>
<?supplied-pmid 21816493?><pub-id pub-id-type="pmid">21816493</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref070">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Van Someren</surname><given-names>EJ</given-names></name>, <name><surname>Kessler</surname><given-names>A</given-names></name>, <name><surname>Mirmiran</surname><given-names>M</given-names></name>, <name><surname>Swaab</surname><given-names>DF</given-names></name>. <article-title>Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients</article-title>. <source>Biol Psychiatry</source>. <year>1997</year>;<volume>41</volume>: <fpage>955</fpage>–<lpage>963</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0006-3223(97)89928-3</pub-id>
<?supplied-pmid 9110101?><pub-id pub-id-type="pmid">9110101</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Lockley</surname><given-names>SW</given-names></name>, <name><surname>Gooley</surname><given-names>JJ</given-names></name>. <article-title>Circadian Photoreception: Spotlight on the Brain</article-title>. <source>Curr Biol</source>. <year>2006</year>;<volume>16</volume>: <fpage>795</fpage>–<lpage>797</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0262955.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Borbely</surname><given-names>AA</given-names></name>. <article-title>A two process model of sleep regulation</article-title>. <source>Hum Neurobiol</source>. <year>1982</year>;<volume>1</volume>: <fpage>195</fpage>–<lpage>204</lpage>. <?supplied-pmid 7185792?><pub-id pub-id-type="pmid">7185792</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Jindal</surname><given-names>RD</given-names></name>, <name><surname>Thase</surname><given-names>ME</given-names></name>. <article-title>Treatment of insomnia associated with clinical depression</article-title>. <source>Sleep Med Rev</source>. <year>2004</year>;<volume>8</volume>: <fpage>19</fpage>–<lpage>30</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S1087-0792(03)00025-X</pub-id>
<?supplied-pmid 15062208?><pub-id pub-id-type="pmid">15062208</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref074">
                <label>74</label>
                <mixed-citation publication-type="journal"><name><surname>Kantermann</surname><given-names>T</given-names></name>, <name><surname>Burgess</surname><given-names>HJ</given-names></name>. <article-title>Average mid-sleep time as a proxy for circadian phase</article-title>. <source>PsyCh J</source>. <year>2017</year>;<volume>6</volume>: <fpage>290</fpage>–<lpage>291</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pchj.182</pub-id>
<?supplied-pmid 29035008?><pub-id pub-id-type="pmid">29035008</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref075">
                <label>75</label>
                <mixed-citation publication-type="journal"><name><surname>Crowley</surname><given-names>SJ</given-names></name>, <name><surname>Wolfson</surname><given-names>AR</given-names></name>, <name><surname>Tarokh</surname><given-names>L</given-names></name>, <name><surname>Carskadon</surname><given-names>MA</given-names></name>. <article-title>An update on adolescent sleep: New evidence informing the perfect storm model</article-title>. <source>J Adolesc</source>. <year>2018</year>;<volume>67</volume>: <fpage>55</fpage>–<lpage>65</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.adolescence.2018.06.001</pub-id>
<?supplied-pmid 29908393?><pub-id pub-id-type="pmid">29908393</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Mattsson</surname><given-names>N</given-names></name>, <name><surname>Cullen</surname><given-names>NC</given-names></name>, <name><surname>Andreasson</surname><given-names>U</given-names></name>, <name><surname>Zetterberg</surname><given-names>H</given-names></name>, <name><surname>Blennow</surname><given-names>K</given-names></name>. <article-title>Association between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients with Alzheimer Disease</article-title>. <source>JAMA Neurol</source>. <year>2019</year>;<volume>76</volume>: <fpage>791</fpage>–<lpage>799</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/jamaneurol.2019.0765</pub-id>
<?supplied-pmid 31009028?><pub-id pub-id-type="pmid">31009028</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref077">
                <label>77</label>
                <mixed-citation publication-type="journal"><name><surname>Pattinson</surname><given-names>CL</given-names></name>, <name><surname>Shahim</surname><given-names>P</given-names></name>, <name><surname>Taylor</surname><given-names>P</given-names></name>, <name><surname>Dunbar</surname><given-names>K</given-names></name>, <name><surname>Guedes</surname><given-names>VA</given-names></name>, <name><surname>Motamedi</surname><given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Elevated tau in military personnel relates to chronic symptoms following traumatic brain injury</article-title>. <source>J Head Trauma Rehabil</source>. <year>2020</year>;<volume>35</volume>: <fpage>66</fpage>–<lpage>73</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/HTR.0000000000000485</pub-id>
<?supplied-pmid 31033745?><pub-id pub-id-type="pmid">31033745</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref078">
                <label>78</label>
                <mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>F</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Cai</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome</article-title>. <source>Mol Med Rep</source>. <year>2017</year>;<volume>16</volume>: <fpage>6334</fpage>–<lpage>6339</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3892/mmr.2017.7399</pub-id>
<?supplied-pmid 28901415?><pub-id pub-id-type="pmid">28901415</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref079">
                <label>79</label>
                <mixed-citation publication-type="journal"><name><surname>Van Der Ploeg</surname><given-names>ES</given-names></name>, <name><surname>O’Connor</surname><given-names>DW</given-names></name>. <article-title>Methodological challenges in studies of bright light therapy to treat sleep disorders in nursing home residents with dementia</article-title>. <source>Psychiatry Clin Neurosci</source>. <year>2014</year>;<volume>68</volume>: <fpage>777</fpage>–<lpage>784</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/pcn.12192</pub-id>
<?supplied-pmid 24735203?><pub-id pub-id-type="pmid">24735203</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0262955.ref080">
                <label>80</label>
                <mixed-citation publication-type="journal"><name><surname>Ancoli-Israel</surname><given-names>S</given-names></name>, <name><surname>Cole</surname><given-names>R</given-names></name>, <name><surname>Alessi</surname><given-names>C</given-names></name>, <name><surname>Chambers</surname><given-names>M</given-names></name>, <name><surname>Moorcroft</surname><given-names>W</given-names></name>, <name><surname>Pollak</surname><given-names>CP</given-names></name>. <article-title>The role of actigraphy in the study of sleep and circadian rhythms</article-title>. <source>Sleep</source>. <year>2003</year>;<volume>26</volume>: <fpage>342</fpage>–<lpage>392</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/sleep/26.3.342</pub-id>
<?supplied-pmid 12749557?><pub-id pub-id-type="pmid">12749557</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
